<?xml version="1.0" encoding="utf-8"?>
<add>
	<doc>
		<field name="docid">BR-TU.19009</field>
		<field name="filename">26108_Lucchesi_Carolina_D.pdf</field>
		<field name="filetype">PDF</field>
		<field name="text">
i 

 



ii 

 

 

 

 

 

 

  



iii 

 

  



iv 

 

AGRADECIMENTOS 

 

Aos meus pais por me mostrarem o valor do conhecimento, à minha mãe Julia que 

nunca negou um tostão para comprar livros, mesmo em momentos de grande dificuldade e ao 

meu pai Dom Lucchesi in memoriam.  

Agradeço a minha família por todo apoio, em especial minha avó Bá que sempre rezou 

muito, meus irmãos e Natassja. 

Aos meus sogros Elisa e Álvaro, os quais sempre me trataram como filha, me dando 

apoio, carinho e incentivo em todos os momentos. 

Ao meu marido e amigo Daniel, pela bolsa DNPq por todo suporte e paciência mesmo 

nos momentos maís críticos. 

Aos amigos de bancada Larissa, Silvia Cristina, Andréa, Lucas, Alis, Hsi Chin, e em especial 

ao Amém, André e Román por darem de comer, limpar, conversar e cantar para a menina nos 

momentos em que lhes fiz falta e ao Marcelo José, pela preocupação com a cisticercose. 

Agradeço ao professor Paulo pela orientação, apoio, conhecimento e emails divertidos. 

Não tenho palavras suficientes para agradecer à professora Eliana, a qual sempre esteve 

ao meu lado, não importando a presença física. Nem em uma eternidade pagarei tudo que fez 

por mim.  

A equipe de pesquisa do Centro de Tecnologia da Informação Renato Archer (CTI), 

Marcelo Oliveira, Izaque Maia, Jorge Vicente da Silva por todo apoio, colaboração e 

competência e a Dra Betina Ferreira, pela amizade, colaboração e auxílio. 

Ao Programa de Pós-Graduação em Biologia Celular e Estrutural, especialmente a 

secretária do programa, Líliam, a qual muito me ajudou, além da extrema competência. 

Agradeço aos programas de auxílio e pesquisa, FAPESP, Capes e CNPq por todo auxílio à 

pesquisa de forma geral. 

 



v 

 

SUMÁRIO 
 
 

AGRADECIMENTOS .................................................................................................................................................... IV 
LISTA DE ABREVIAÇÕES E SIGLAS ............................................................................................................................... VI 
ARTIGOS QUE COMPÕEM ESTA TESE ........................................................................................................................ VII 
RESUMO................................................................................................................................................................... VIII 
ABSTRACT ................................................................................................................................................................... X 
CAPÍTULO 1 ................................................................................................................................................................ 12 
I. INTRODUÇÃO .................................................................................................................................................. 13 
1. BIOLOGIA DO TECIDO ÓSSEO ............................................................................................................................ 14 
1.1 CÉLULAS ÓSSEAS ................................................................................................................................................ 15 
1.1.1 OSTEOBLASTOS E OSTEÓCITOS ......................................................................................................................... 15 
1.1.2 OSTEOCLASTOS ................................................................................................................................................. 16 
1.2 OSTEOGÊNESE ...................................................................................................................................................... 16 
1.3 PROTEÍNAS ÓSSEAS .............................................................................................................................................. 19 
1.3.1 COLÁGENO ........................................................................................................................................................ 19 
2. REGENERAÇÃO ÓSSEA ...................................................................................................................................... 20 
3. ENGENHARIA DE TECIDO ÓSSEO ....................................................................................................................... 22 
3.1 POLÍMEROS ......................................................................................................................................................... 24 
3.1.1 POLÍMEROS SINTÉTICOS: PHB, PCL E PLGA. ....................................................................................................... 25 
3.2 TRATAMENTO DE SUPERFÍCIES ............................................................................................................................ 28 
II. OBJETIVOS ....................................................................................................................................................... 30 
CAPÍTULO 2 ................................................................................................................................................................ 31 
CAPÍTULO 3 ................................................................................................................................................................ 39 
CAPÍTULO 4 ................................................................................................................................................................ 63 
CAPÍTULO 5 ................................................................................................................................................................ 83 
CONCLUSÕES ............................................................................................................................................................. 84 
CAPÍTULO 6 ................................................................................................................................................................ 85 
REFERÊNCIAS BIBLIOGRÁFICAS .................................................................................................................................. 86 
APÊNDICE ................................................................................................................................................................... 96 

 

 



vi 

 

 

LISTA DE ABREVIAÇÕES E SIGLAS 

 

PCL – Poli (?-caprolactona) 

PLGA – Poli (ácido lático-co-ácido glicólico) 

PHB – Poli(hidroxibutirato)  

PHBV – Poli(hidroxubutirato-co-hidroxivalerato) 

PHA - Polihidroxialcanoatos 

3D – tri-dimensional  

HA - Hidroxiapatita 

MSC – Células Tronco Mesenquimais, do inglês Mesenchymal Stem Cells. 

DNA – Ácido Desoxirribonucleico 

GS – Sulfato de Gentamicina  

MEC – Matrix extracelular 

SFF – Forma sólida livre, do inglês solid free form  

SLS – Sinterização seletiva a laser, do inglês Selective laser sintering 

RP – Prototipagem rápida, do inglês rapid prototyping 

MTT - (3-(4,5-dimetiltiazol-2-il)-2,5-difeniltetrazolium bromide), tetrazolium 

DMEM – Meio Eagle modificado por Dulbecco, do inglês Dulbelcco’s modified Eagle’s 

médium 

UV - ultravioleta 

MEV – Microscopia eletrônica de varredura 

BMP – Porteína morfogenética óssea, do inglês Bone Morphogenetic Protein  

OP – Proteína osteogênica, do inglês osteogenic protein 

MMP - metaloproteinase 

COP – Centro de ossificação primária 

PBS – Tampãp fosfato salino, do inglês phosphate buffer saline 

FBS – Soro fetal bovino, do inglês fetal bovine serum 

DMSO – Dimetil Sulfoxido 

 

http://en.wikipedia.org/wiki/Di-
http://en.wikipedia.org/wiki/Di-
http://en.wikipedia.org/wiki/Thiazole
http://en.wikipedia.org/wiki/Phenyl


vii 

 

 

 
 
ARTIGOS QUE COMPÕEM ESTA TESE 

 
 
Lucchesi, C.; Barbanti, S.H.; Joazeiro, P.P.; Duek, E.A.R. Cell Culture on PCL/PLGA Blends. 
Journal Applied Polymer Science, v.115, n.5, p.2609-2615, 2010. DOI 10.1002/app.29919 
 
 
Lucchesi, C.; Lorenzon, R.Z.; Ferreira, B.M.P.; Oliveira, M.F.; Maia, I.A.; Silva, J.V.L.; Duek, 
E.A.R.; Joazeiro, P.P. Rapid prototyping of poly(hydroxybutyrate) scaffolds treated by plasma to 
support osteoblastic cells from rabbit calvaria. Será submetido ao Journal of Material Science 
Materials in Medicine. 
 
 
Lucchesi, C.; Santos, C.C.; Ferreira, B.M.P.; Oliveira, M.F.; Maia, I.A.; Silva, J.V.L.; Duek, 
E.A.R.; Joazeiro, P.P.  Osteoblast cells on 3D PHB obtained by rapid prototyping: in vivo study. 
Será submetido ao Journal of Biomedical Material Reasearch. 

 
 



viii 

 

RESUMO 

 

Os polímeros biorreabsorvíveis, tais como, PHB, PCL e PLGA, têm sido estudados como 

dispositivo para engenharia de tecidos por serem biocompatíveis, suportarem o crescimento e 

diferenciação celular e os produtos de sua degradação serem atóxicos. No entanto, a escolha do 

biomaterial depende das necessidades exigidas para uma determinada aplicação.  

Os suportes para engenharia de tecidos devem se basear na construção de réplicas 

biológicas in vitro, como que o biomaterial se tornasse parte integrada para transplante in vivo 

para a recuperação de perdas ou mau funcionamento de tecidos ou órgãos, devendo 

subseqüentemente, atuar sem agredir o restante do organismo, isto é, sem o risco de rejeição ou 

complicação. 

Muitas estratégias têm sido desenvolvidas com o intuito de substituir tecidos ou órgãos 

danificados, incluindo a aplicação de suportes tridimensionais (3D), os quais devem possuir 

características estruturais e mecânicas para guiar a proliferação e espalhamento de células in vitro 

e in vivo.  Os suportes, feitos de materiais sintéticos ou naturais, servem como substitutos para a 

matriz extracelular (MEC) nativa. Ênfase especial é dada as técnicas com controle 

computadorizado, como a fabricação sólida com forma livre (SFF), conhecida como 

prototipagem rápida (RP), a qual permite preparar suportes 3D com geometrias complexas, tanto 

externamente como internamente, além de ser uma técnica rápida e de baixo custo.  

Além disso, grande parte dos polímeros possuem superfície hidrofóbica, característica 

inadequada para a maior parte dos diferentes tipos celulares, o que dificulta aplicação na engenharia 

de tecidos. Uma alternativa a este problema é o tratamento da superfície por plasma. Este 

tratamento induz modificação restrita ao topo da superfície, conferindo carater hidrofílico à 

superfície, dependendo do gás utilizado.  

Neste estudo, arcabouços de polímeros biorreabsorvíveis PCL, PLGA e PHB foram 

preparados por diferentes técnicas, casting e sinterização seletiva a laser, avaliando-se o 

comportamento de células osteoblásticas diferenciadas sobre os biomateriais poliméricos 

tridimensionais. Inicialmente o trabalho foi desenvolvido com os polímeros PCL e PLGA 

preparando-se blendas poliméricas, as quais demonstraram melhorar as características gerais dos 

polímeros, quando utilizados como dispositivos para tecido ósseo, como as propriedades 



ix 

 

mecânicas. Com o intuito de aprimorar o design tridimensional do material, optou-se pela 

realização da técnica de sinterização seletiva a laser. No entanto, a técnica exige uma grande 

quantidade de material e devido ao alto do custo do PCL e PLGA, este foi substituído pelo 

polímero PHB, o qual é produzido pela indústria nacional Biocycle possuindo um baixo custo e 

ainda ser biocompatível. Os dados são apresentados em capítulos independentes. 

Arcabouços porosos de PCL, PLGA e suas blendas foram preparados pela técnica de 

evaporação do solvente, onde sais de citrato de sódio com granulometria de 180-250 µm, foram 

adicionados a solução para a promoção dos poros, sendo posteriormente lavados do arcabouço. 

Células osteoblásticas provenientes de calota craniana de ratos Wistar foram semeadas sobre os 

arcabouços, sendo avaliado o comportamento de citoxicidade do material e o comportamento de 

adesão e morfologia celular através de ensaios bioquímicos e MEV.  

Os arcabouços de PHB foram obtidos por uma das técnicas de RP, a sinterização seletiva a 

laser (SSL), sendo sua superfície modificada por plasma pelos gases oxigênio e nitrogênio. Células 

osteoblásticas provenientes de calota craniana de coelhos foram semeadas sobre os arcabouços 

realizando-se o estudo in vitro, através de análises bioquímicas pela técnica do MTT, para 

viabilidade e adesão celular, quantificação de colágeno por Sírius Red e Microscopia Eletrônica de 

Varredura (MEV). Para o estudo in vivo, após o cultivo celular sobre os arcabouços, defeitos ósseos 

foram provocados em coelhos e os arcabouços contendo as células foram então implantados, 

avaliando-se a interação PHB/osteoblasto/tecido, através da análise histológica.  

Todos os arcabouços estudados, PCL, PLGA e suas blendas, assim como o PHB, não 

apresentaram índices de citotoxicidade, permitiram às células a capacidade de adesão, proliferação 

e síntese de matriz, mantendo seu fenótipo osteoblástico. As amostras de PHB tratadas por plasma 

de Nitrogênio mostrou melhorar a capacidade de adesão celular. Os arcabouços de PHB contendo 

células mostraram-se os mais adequados para o preenchimento de defeitos ósseos, melhorando o 

processo de regeneração apresentando uma boa osteointegração. A sinterização seletiva a laser 

apresentou-se uma excelente técnica para a obtenção de PHB 3D para a Engenharia de Tecidos. 



x 

 

ABSTRACT  

The bioresorbable polymers as, PHB, PCL and PLGA have been studied as device for 

Tissue Engineering for their biocompatibility and to support the cell growth and differentiation 

and their degradation products are nontoxics. However, the choice of the biomaterial depends on 

the needs demanded for a certain application.    

The scaffolds for tissue engineering have to be designed to mimetize the biological 

conditions in vitro to became part integrated for transplant for the recovery of tissue or organs 

lost or without function, and subsequently, to work in a cordial way with the remaining of the 

organism without the rejection risk or complication.   

A lot of strategies have been developed with to substitute damaged tissues or organs, and 

it has been used the application of three-dimensional supports (3D), which should possess 

structural and mechanical applications to guide the cells proliferation and spread in vitro and in 

vivo. The scaffolds, made from synthetic or natural materials, serve as substitutes for the 

extracellular matrix (ECM) native. Special emphasis is given the techniques with computerized 

control, as the free solid form (SFF), known as rapid prototyping (RP), which allows to prepare 

three-dimensional supports with complex geometries, so much externally as internally, besides to 

be a fast technique with low cost.    

Besides, great part of the polymers possess hydrophobic surface, inadequate characteristic 

for most of the different cell types, which is not desirable for tissue engineering applications. An 

alternative to this problem is the surface treatment by plasma. Plasma treatment induces restricted 

modification to the top of the surface, improving the surface hydrophilicity, depending on the gas 

used.  

In this study, scaffolds of bioresorbable polymer PCL, PLGA e PHB were prepared by 

different techniques, casting and selective laser sintering, being evaluated the osteoblast cells 

behavior on the 3D polymer scaffolds.  

Previously we developed the studies preparing the polymeric blends with PCL and PLGA, 

which demonstrated improve the general characteristic of the material, as the mechanical 

properties, as devices for bone tissue. With the intention to improve the design of the scaffolds, 

we chose for the selective laser sintering technique. However, the technique demands a great 



xi 

 

amount of material and due to the high cost of PCL and PLGA, those weres substituted by  PHB 

polymer, which is produced by Brazilian industry Biocycle with low cost and still to be 

biocompatible. For those reasons the data are presented in independent chapters. 

 PCL, PLGA porous scaffolds and their blends were prepared those scaffolds by casting 

solvent, and sodium citrate with 180-250 µm were added to the solution for porous formation 

when the salt was washed later of the scaffolds. Osteoblast cells from rat Wistar calvaria were 

seemed on the scaffolds, being evaluated the behavior of cell adhesion and viability behavior, cell 

morphology through biochemical assays, and scanning electron microscopy.  

Three-dimensional PHB scaffolds were obtained by selective sintering laser (SSL), with 

the surface modified by nitrogen and oxygen plasma. Osteoblast cells obtained from rabbit 

calvaria were seemed on the scaffolds to the in vitro studies, through biochemical analyses by 

MTT test for cell viability and cell adhesion, collagen quantification of by Sirius Red 

colorimetric assay and scanning electron microscopy (SEM). For the in vivo studies, bone defects 

were provoked in rabbits and they were filling out with 3D PHB with osteoblast cells culture 

prior implant. We evaluated the PHB/osteoblast/tissue, interaction through the histological 

analysis.  

All the scaffolds studied PCL, PLGA and their blends, as well as the PHB did not showed 

cytotoxicity effects, allowed cells adhere, proliferated, and matrix synthesized, maintaining their 

osteoblastic phenotype.   

The PHB samples treated by nitrogen plasma have been showed to improve the cell 

adhesion. The PHB scaffolds with cell seeded previously demonstrated to be more suitable for 

filling out bone defects, improving the regeneration process showing a good osteointegration. 

The selective laser sintering was excellent technique to obtain PHB scaffolds for Tissue 

Engineering. 

  

 

 

 

 



12 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CAPÍTULO 1 



13 

 

I. INTRODUÇÃO 

 

A incidência de defeitos ósseos devido a fraturas, tumores e infecções tem-se elevado com o 

aumento da expectativa de vida da população, gerando problemas de grande impacto social (World 

Health Organization, 2003). Aproximadamente 150 doenças ou síndromes relacionadas a osso foram 

diagnosticadas, sendo geralmente progressivas e causadoras de dor. No que diz respeito à reparação das 

fraturas entre 5 a 10% dos casos que ocorrem anualmente nos EUA, resultam em reparo ósseo lento e 

ineficiente (Li &amp;amp; Wosney, 2001); e entre 5-35% das cirurgias de fusão vertebral resultam em insucesso no 

processo de fusão (Ludwig et al, 2000).  

Os custos na área da saúde têm se elevado, devido à necessidade frequente de se substituir o 

tecido ósseo. A cada ano, milhões de cirurgias para implantes são realizadas para o reparo ou cura de um 

órgão. Os implantes se constituem de enxertos autólogos e homólogos, cimentos ósseos, materiais 

poliméricos, metais e cerâmicas (Ishaug et al, 1997). Atualmente as estratégias que utilizam enxertos 

autólogos se mostram favoráveis, nesse tipo de reparação, devido às características de osteoindução, 

osteocondução e por não causarem resposta imune (Marquis et al, 2009). Por outro lado, possuem 

limitação na quantidade de tecido que pode ser extraído, além de morbidez do doador. Esse fato 

incentivou as buscas por métodos alternativos para reconstituição de grandes defeitos ósseos.  

A limitação nas técnicas existentes gera a necessidade de se buscar novos métodos para 

regeneração óssea, demandando uma variedade de terapias e implantes de materiais dependendo do 

tipo e tamanho do defeito. Dessa busca, surge a Engenharia de Tecidos, ciência que emerge como uma 

alternativa promissora para o tratamento de perda ou mau funcionamento tecidual, combinando 

células, biomaterial e fatores físico-químicos e bioquímicos para melhorar ou substituir funções 

biológicas (Langer &amp;amp; Vacanti, 1993).  

A interação células-biomateriais é de fundamental importância, pois influencia os subseqüentes 

processos biológicos como diferenciação e proliferação celular (Marquis et al 2009). Além disso, o 

processo de adesão celular é um importante requerimento para o sucesso da incorporação do implante 

ou a colonização do arcabouço para o reparo do tecido. No presente estudo, o comportamento de 

células ósseas foi estudado sobre polímeros sintéticos, preparados por diferentes técnicas, com o 

propósito de preenchimento ósseo em locais de difícil reparo tecidual.  

  



14 

 

1. BIOLOGIA DO TECIDO ÓSSEO 

 

 O tecido ósseo é uma forma especializada de tecido conjuntivo, sendo um importante  elemento 

do esqueleto. Este tecido é composto pela matriz orgânica e inorgânica. A matriz orgânica é composta 

por aproximadamente 95% de fibras colágenas, tipo I e III, e proteínas não-colágenas, como 

osteocalcina, osteopontina, proteína osteoprogenitora (OP-1) ou proteína morfogenética óssea (BMP-7), 

osteonectina, atualmente denominada SPARC (do inglês Secreted protein acidic rich in cystein), 

sialoproteína óssea, glicosaminoglicano, células, entre outras. Já a matriz inorgância é constituída de 

água, 65-70% de compostos de fosfato de cálcio, principalmente na forma de cristais de hidroxiapatita 

Ca10(PO4)6(OH)2 (HA), e composta ainda por bicarbonato, magnésio, potássio, sódio, citrato em pequenas 

quantidades (Junqueira &amp;amp; Carneiro, 2004). Diferencia-se de outros tecidos conjuntivos pelo fato de sua 

matriz tornar-se mineralizada. Este tecido é composto por osteoblastos, osteoclastos, células 

mesenquimais osteoprogenitoras e osteócitos.  

 O tecido ósseo é dinâmico, altamente vascularizado e com a capacidade única de regeneração e 

remodelação sem a ocorrência de fibrose (Buckwalter et al 1996; Kneser et al, 2006). É responsável pelo 

suporte mecânico do esqueleto, suportando carga, promovendo proteção aos órgãos internos e os 

movimentos, juntamente com o sistema muscular. Serve ainda como reserva mineral e tem a capacidade 

de mobilizar seu estoque rapidamente, quando se faz necessária a homeostase do nível de íons cálcio no 

sangue. Esta diversidade funcional requerida ao tecido ósseo reflete na complexidade de sua arquitetura 

(Kneser et al, 2006).  

 Em indivíduos humanos adultos, os ossos têm arranjo trabecular e compacto, além da cavidade 

medular. Os ossos trabeculares ou esponjosos são organizados em poros assemelhando-se a uma 

esponja, que permite o alojamento da medula óssea, estando presente na metafise dos ossos longos, 

crista ilíaca e corpos vertebrais. Já os óssos compactos, mostram-se sólido, com porosidade menor que 

10%, sendo revestido extremamente por uma membrana de tecido conjuntivo, o periósteo e 

internamente, pelo endósteo. Ambos contêm osteoblastos, osteoclastos e seus progenitores. Este 

arranjo sólido faz parte dos ossos longos, curtos e achatados, sendo de grande importância para o 

suporte do esqueleto (Ackerman et al, 1976; Datta et al, 2008). 

A capacidade regenerativa dos ossos é dependente da quantidade de massa óssea perdida e/ou 

danificada. Quando o defeito ocorrido não permite que o tecido ósseo se regenere por ele mesmo, este 



15 

 

defeito é denominado como defeito crítico (Prado et al, 2006; Jan et al 2006; Schmitz &amp;amp; Hollinger, 1986). 

O defeito crítico varia de espécie para espécie, sexo, idade, local do defeito e ainda do metabolismo 

individual. Em geral, em calota craniana de coelhos New Zealand, o defeito crítico é estimado em 15mm 

de diâmetro (Hollinger &amp;amp; Kleinschmidt 1990), no entanto, existem várias discussões na literatura  sobre o 

tamanho apropriado do defeito crítico. Um estudo realizado por Hokugo et al (2007), onde criou-se um 

defeito crítico com 5mm de diâmetro, verificou-se que não ocorreu  a completa regeneração tecidual 

após 60 dias. 

  

  
1.1 CÉLULAS ÓSSEAS 

 

As células ósseas descritas são os osteoblastos, osteócitos e osteoclastos, os quais possuem 

diferentes origens e funções, sendo de crucial importância na remodelação óssea. No entanto, não 

podemos deixar de citar as células mesenquimais de medula óssea (BMSCs do inglês, bone marrow 

stromal cells), as quais são capazes de se diferenciar em uma variedade de tipos celulares incluindo 

osteoblastos. Durante este processo de osteoblastogênese, os osteoblastos passam por diversos eventos 

morfológicos e moleculares, a célula adquire a capacidade de sintetizar e depositar matriz extracelular 

mineralizada, característica do tecido óssseo (Ducy et al, 2000; Lavery et al, 2009). Esta transformação é 

um processo multi-passos altamente dependente de sinais provenientes do ambiente e justamente 

regulados.  

 

1.1.1 OSTEOBLASTOS E OSTEÓCITOS 

 

Os osteoblastos derivam de células mesenquimais provenientes da medula óssea, do periósteo 

ou endósteo. Quando ativos, possuem proeminente retículo endoplasmático rugoso, assim como, 

complexo de Golgi, devido à alta síntese de proteínas como, colágeno, SPARC, osteonectina, 

osteocalcina, glicosaminoglicano entre outras. São ricos em fosfatase alcalina, enzima fundamental na 

deposição de matriz mineralizada. Encontram-se na matriz da superfície óssea existente (osteoblastos de 

superfície) ou depositando camadas de tecido ósseo recém sintetizadas sobre estas (osteoblastos 

mesenquimais) ou acabam morrendo por apoptose (Shapiro, 1988; Marie, 2008; Marquis et al, 2009). 



16 

 

Alguns osteoblastos permanecem livres na superfície, enquanto outros se tornam gradativamente 

aprisionados pela matriz que a própria célula secreta. Este material recém produzido é conhecido como 

ósteon e o osteoblasto aprisionado na matriz mineralizada, passa a ser denominado osteócito, 

continuando a secretar matriz em torno de si, porém em quantidade reduzida. Apesar de aprisionado na 

matriz, os osteócitos não se encontram isolados, ligam-se a osteócitos vizinhos por projeções celulares, 

através de canalículos, formando junções comunicantes (Alberts et al, 2005; Datta et al 2008). 

Quando avaliados in vitro, a diferenciação requer a presença de vários fatores os quais incluem 

fatores de crescimento, dexametasona, ?-glicerofosfato e L-ácido ascórbico (Bruder &amp;amp; Caplan 2000). 

Outros elementos como a proteína osteoprogenitora, tem sido estudados por Lavery e colaboradores 

(2009) descrevendo a bioatividade da OP-1 durante o processo inicial de diferenciação de células 

mesenquimais humanas em osteoblastos in vitro, sendo estas informações importantes para uma 

melhor compreensão das contribuições individuais das BMPs, durante a formação óssea humana (Lavery 

et al 2009). 

 

1.1.2 OSTEOCLASTOS 

 

Os osteoclastos são células multinucleadas gigantes, diferenciadas a partir de células de 

linhagem hematopoiética da medula óssea, os monócitos/macrófagos (Dougall &amp;amp; Chaisson, 

2006), sendo responsáveis pela reabsorção óssea. Seu citoplasma contém retículo 

endoplasmático e complexo de Golgi bem desenvolvidos, muitas mitocôndrias e lisossomos. 

Sintetizam e secretam enzimas proteolíticas, as metaloproteinases (MMP), catepsina K e 

fosfatase ácida, as quais atuam erodindo a matriz protéica (Vaananen, 2005; Zeng et al, 2006). 

 

 

1.2 OSTEOGÊNESE 

O processo de formação óssea durante o desenvolvimento do esqueleto envolve uma complexa 

coordenação de múltiplos tipos celulares e tecidos. O desenvolvimento ósseo ocorre através de dois 

padrões de formação óssea: intramembranosa e endocondral. No entanto, deve se ter em mente a 



17 

 

distinção em osso como um tecido, contendo células ósseas e matriz mineralizada e osso como um 

órgão, incluindo o tecido ósseo, cartilaginoso, fibroso, medula e vasos sanguíneos. 

Nos mamíferos, a formação óssea é um evento tardio no embrião e ainda um dos últimos 

estágios no desenvolvimento do esqueleto. Em alguns elementos do esqueleto, como parte do crânio e 

clavícula, ocorrem grupos de células mesenquimais que se diferenciam diretamente em osteoblastos, 

formando o centro de ossificação primária (COP) e iniciando a produção de matriz não mineralizada, o 

osteóide. Com a mineralização, os osteoblastos são aprisionados na matriz transformando-se em 

osteócitos. Durante o processo de ossificação intramembranosa, ocorre à formação de vários COPs, os 

quais crescem radialmente, dando origem aos ossos primários, os quais são invadidos por vasos 

sanguíneos e células mesenquimais, formando-se a medula óssea (Hall &amp;amp; Miyake 1995; Huang et al, 

1997).  

Para o restante do esqueleto, as células da condensação mesenquimal diferenciam-se em 

condrócitos formando a cartilagem “análoga” aos ossos futuros. Na periferia desta cartilagem, células do 

pericôndrio diferenciam-se em osteoblastos, enquanto os condrócitos tornam-se hipertróficos. 

Eventualmente, a matriz ao redor destes condrócitos hipertróficos se calcifica e vasos sangüíneos 

presentes na matriz trazem os osteoblastos (Horton, 1993; Erlebacher et al, 1995).  Uma vez que a matriz 

é depositada, a medula óssea se forma e os primeiros osteoclastos aparecem (Hofstetter et al, 1995). 

Assim, os estágios seqüentes de formação da cartilagem análoga, calcificação da cartilagem e formação 

óssea, caracterizam a ossificação endocondral. Neste modelo de ossificação, os osteoblastos precedem a 

diferenciação dos osteoblastos (Karsenty, 1999; Deng et al, 2008). 

Os primeiros estágios do desenvolvimento do esqueleto em vertebrados são dependentes de 

genes que controlam a distribuição e proliferação de células da crista neural, escleroma e placa lateral 

mesodérmica ocorrendo a condensação das células mesenquimais, pela qual estas de diferenciam em 

osteoblastos, no caso do tecido ósseo (Deng et al, 2008). Esta condensação celular é o principal estágio 

no desenvolvimento do esqueleto e outros tecidos mesenquimais. As primeiras observações de 

condensação celular foram realizadas por Strelzoff em 1873 e van der Stricht em 1890, os quais 

descreveram os processos de osteogênese e condrogênese em membros de aves, e Parsons em 1905 

publicou um artigo seguindo os mesmos passos. Até aquele momento, raras eram as observação de 

osteogênese em mamíferos (Fell 1925; Gould et al, 1992). Segundo Hall &amp;amp; Miyake (1992), as 

condensações celulares são iniciadas pelo aumento na atividade mitótica ou pela agregação de células 

similares ao redor de um centro. Condensação é definida como a agregação de células pela qual os 



18 

 

tecidos se formam durante o desenvolvimento embrionário e pela qual a condrogênese e osteogênese 

são iniciadas durante seu reparo e/ou regeneração (Hall &amp;amp; Miyake 1995).  

Recentemente, Hall &amp;amp; Miyake (2000), descreveram a condensação como a terceira entre quatro 

fases da esqueletogênese. A primeira é a migração das células para o local da futura esqueletogênese; a 

segunda é a interação tecidual (epitelial-mesenquimal) que resulta na formação da condensação; e a 

quarta é diferenciação em condroblastos ou osteoblastos (Hall &amp;amp; Mayake 2000). Segundo Ede &amp;amp; Agerbak 

(1968), o tamanho da condensação e a interferência no número de células, afetam a esqueletogênese. A 

condensação reduzida segue um limiar crítico e a esqueletogênese pode não ser iniciada. Porém, um 

aumento na condensação pode resultar num esqueleto muito grande e/ou deformado. Este tamanho é 

regulado através da sinalização envolvendo as BMPs (Hall &amp;amp; Miyake, 1995).  

Ambos os mecanismos, endocondral e intramembranoso, também são descritos durante a 

regeneração do tecido, dependendo dos elementos disponíveis no local onde ocorreu a lesão (Shapiro, 

2008). 

Durante a formação óssea, os osteoblastos sintetizam e depositam colágeno tipo I/III e com o 

auxílio de proteínas da matriz extracelular, cristais de fosfato de cálcio são depositados sobre as fibras 

colágenas (Shapiro, 2008).  

 Significante progresso tem sido realizado nos últimos anos para a compreeensão dessa rede de 

mecanismos moleculares que controlam a diferenciação osteogênica (Deng et al, 2008). Estimulantes 

aspectos no desenvolvimento do esqueleto dos vertebrados têm sido obtidos através de estudos 

genéticos e moleculares em modelos animais e humanos com desordens inerentes na morfogênese, 

organogênese e crescimento do esqueleto (Olsen et al, 2000, Harada &amp;amp; Rodan 2003; Ralston &amp;amp; 

Crombrugghe, 2006) 

 Atsawasuwan e colaboradores (2005) estudaram o processo de expressão das isoformas da 

enzima lisil oxidase, a qual inicia a ligação intermolecular das moléculas colágenas nos resíduos de lisina 

e hidroxilisina, em células osteoblásticas MC3T3-E1 durante o processo de mineralização das fibras, 

indicando que sua expressão é altamente regulada durante a diferenciação dos osteoblastos, a qual 

sugere que a enzima tenha papel durante a estabilização das fibras e sua subseqüente mineralização 

(Atsawasuwan et al 2005). Num estudo realizado in vivo, Verdelis e colaboradores (2008) atribuíram, em 

parte, a capacidade da dentina sialoproteína como reguladora da mineralização e remodelação em óssos 

de camundongos. Genge e colaboradores (2008), baseados em nucleadores de fosfato de cálcio amorfo, 

estudaram os efeitos da proteína anexina-5 (Anx-5), uma proteína lipídeo dependente para ligar-se ao 



19 

 

cálcio. Neste estudo, os autores demonstraram um aumento na nucleação e formação dos minerais em 

colágeno tipo II e IX na presença da proteína. No entanto, o processo de mineralização in vivo continua 

não sendo bem compreendido. 

 

1.3 PROTEÍNAS ÓSSEAS 

 

 Diversas proteínas fazem parte do tecido ósseo, sendo divididos em proteínas colágenas, como o 

colágeno do tipo I e III, e as proteínas não colágenas, como sialoproteína óssea, SPARC, osteocalcina, 

osteopontina, a grande família de proteínas morfogenéticas ósseas (BMPs), entre outras. No entanto, 

serão descritas somente as proteínas em foco no presente estudo. 

 

1.3.1 COLÁGENO 

 

O colágeno é o tipo mais abundante de proteína no organismo, constituindo uma família de 

proteínas, as quais exercem diferentes funções, principalmente estruturais.  Atualmente, são conhecidos 

20 tipos de proteínas colágenas diferentes, podendo ser classificadas em grupos: formadores de fibras 

longas, como colágeno tipo I, II, III, V e IX; colágenos associados a fibrilas, como tipo IX e XII; colágeno 

formador de redes, como tipo IV; colágeno de ancoragem, como tipo VII (Junqueria &amp;amp; Carneiro 2004).  

O colágeno do tipo I e III, formadores de fibras longas, são os encontrados nos ossos, sendo mais 

bem abordados no estudo. A molécula colágena contém 3 cadeias polipeptídicas e cada cadeia possui 

1000 aminoácidos e uma sequência repetida de aminoácidos Gly-X-Y (na qual, X e Y podem ser qualquer 

aminoácido acídico, mas geralmente prolina e hidroxiprolina, respectivamente). Essas moléculas são 

conhecidas como pro-colágeno, os quais se agregam em subunidades para formar fibrilas, arranjadas em 

três cadeias ?-pro, unidas  por pontes de hidrogênio e interações hidrofóbicas. Esta molécula pró-

colágena é enviada pela célula para o ambiente extracelular por exocitose, sofrendo ação da enzima pró-

colágeno peptidase, a qual cliva os peptídeos de registro, para que estas moléculas, agora conhecidas 

como tropocolágeno, a subunidade colágena básica, possam se agregar formando fibrilas, finas 

estruturas com 10 a 300nm de diâmetro. Um sistema de ligações covalentes intercadeias estabiliza as 

fibras (Patino et al, 2002), esse sistema é possível devido ao trabalho das enzimas: N-proteinase, a qual 

removendo a porção N-propeptídeo; pro-colágeno C-proteinase, a qual remove porção C-propeptídeo; e 



20 

 

lisil-oxidase, enzima responsável por iniciar a ligação inter-molecular entre as fibrilas. A biossíntese do 

colágeno tipo I é o mais estudado até o momento, provavelmente devido a sua alta quantidade no 

organismo. 

O colágeno tem uma gama de propriedades biofísicas e bioquímicas, que fazem desta molécula 

um importante biomaterial. Estas propriedades incluem solubilidade, resistência, mediação entre 

interações intercelulares, estabilidade, biodegradabilidade e baixa imunogenicidade (Patino et al, 2002). 

Com o advento da microscopia eletrônica de transmissão, importantes características em 

pequena escala sobre o colágeno e a estrutura óssea foram descobertas. O pioneiro a descrever este 

advento foi Robinson em 1952, observando os componentes inorgânicos dos ossos, os cristais de 

pequenas formas irregulares e sua relação com a matriz óssea orgânica. Watson &amp;amp; Robinson (1953), 

notaram a presença de formação óssea através do mesmo modelo de banda observado em colágeno 

tipo I não mineralizado, porém corado. A explicação para esse fenômeno foi provida por Hodge &amp;amp; 

Petruska em 1962, que propuseram o modelo de arranjo em bandas do colágeno e estrutura óssea. 

Neste modelo, os minerais se localizam nos espaços ente as fibrilas. Hoje se sabe que o colágeno forma 

uma rede tri-dimensional na qual os cristais se depositam e crescem (Weiner &amp;amp; Traub, 1989).  

 

 

2. REGENERAÇÃO ÓSSEA 

 

Embora os ossos apresentem dureza, estão sujeitos a fraturas, de acordo com o esforço aplicado, 

sendo estas acompanhadas de hemorragia. As células do periósteo (tecido conjuntivo que reveste os 

ossos externamente, excluindo cartilagem articular) e endósteo (tecido conjuntivo que reveste os óssos 

internamente, medula óssea e trabéculas esponjosas) respondem a lesão, ocorrendo rápida proliferação 

de fibroblastos e células mesenquimais, que envolvem a formação da cartilagem e fibrocartilagem (calo 

fibrocartilaginoso), e preenchem o local do defeito. Na base do calo, osteoblastos iniciam a formação da 

matriz óssea, resultando em calo ósseo primário (osso imaturo). Subsequentemente o osso primário é 

remodelado em osso secundário ou lamelar e os vasos sanguíneos do periósteo e endósteo estão 

envolvidos na nutrição óssea. 

 Os ossos têm a capacidade única de se regenerar dependendo do volume danificado, sem o 

desenvolvimento de cicatriz fibrosa, a qual está presente durante cicatrização de feridas em tecidos 



21 

 

moles. Isto é alcançado através dos estágios complexos e interdependentes do processo de cicatrização, 

o qual mimetiza o desenvolvimento altamente regulado do esqueleto (Kanczler and Oreffo, 2008; El-

Tamer &amp;amp; Reis, 2009). 

 A remodelação e reorganização do tecido ósseo é resultado de muitos fatores incluindo estímulo 

mecânico, causas metabólicas (como dieta de cálcio, doenças, idade), alterações hormonais e efeito de 

drogas.  

O tipo de regeneração óssea pode ocorrer por diferentes mecanismos e embora a síntese óssea 

seja sempre mediada por células mesenquimais ou osteoblastos de superfície, também irá depender do 

ambiente biofísico, podendo ser: reparo endocondral; reparo ósseo primário, sem a presença de uma 

fase cartilaginosa, mediado exclusivamente por osteoblastos provenientes do sistema de Havers 

intraósseo e osteoclastos; reparo ósseo direto, ocorrendo também sem fase cartilaginosa, no entanto, as 

células derivam da medula óssea; e por distração osteogênica, processo biológico de neoformação óssea 

entre segmentos ósseos que são gradualmente separados por tração controlada. Deve-se ainda 

considerar o local do defeito, uma vez que o ambiente irá prover os recursos celulares, como agente 

primário para o reparo (Shapiro, 2008). 

No caso de reparo ósseo endocondral, após a fratura, forma-se hematoma contendo rede de 

fibrina e coágulo, os quais servem de arcabouço para o crescimento celular. Esta primeira etapa é 

caracterizada por uma fase inflamatória e juntamente com o coágulo sanguíneo são essenciais para o 

reparo. Células mesenquimais provenientes do periósteo proliferam e outras linhagens 

osteoprogenitoras se diferenciam e o reparo ósseo tem início a partir da periferia do córtex ósseo. 

Próximo a fratura, ocorre hipoxia devido ao dano no suprimento sanguíneo, permitindo que células 

mesenquimais se diferenciem em condroblastos, dando origem a matriz cartilaginosa. Estas massas 

cartilaginosas e fibrosas formam o calo ósseo, o qual irá estabilizar o local da fratura, sendo 

posteriormente invadido por vasos sanguíneos e tornando-se mineralizado, formando tecido ósseo. Para 

o caso de fratruras que exigem fixação, não ocorre à formação de calo e o reparo ósseo ocorre sem a 

presença de fase cartilagonosa. O tecido ósseo pode ser depositado no córtex e também na cavidade da 

medula, a partir da diferenciação de células mesenquimais, diretamente em osteoblasto (Shapiro, 2008). 

Os defeitos ósseos de grande extensão são um desafio para a cirurgia reconstrutiva. O 

tratamento mais apropriado é o enxerto autólogo de osso. Porém a quantidade de osso apropriada é 

limitada e sua retirada é dolorosa, com risco de infecção, hemorragia, inaptidão cosmética, danos 

nervosos e a perda de função (Damien &amp;amp; Parsons 1991). Uma alternativa para os cirurgiões superarem 



22 

 

este problema é a utilização de biomateriais de origem sintética ou natural, que permite a migração e a 

proliferação das células ósseas (Langer &amp;amp; Vacanti 1993). Entretanto, o sucesso destes materiais no 

reparo de defeitos ósseos de grande porte é limitado. Muitas vezes, estes não possuem as características 

e propriedades osteogênicas e osteoindutiva dos enxertos ósseos.  

Boa regeneração óssea foi obtida por arcabouços reabsorvíveis suplementados com células 

competentes, como por exemplo, células tronco mesenquimais (MSC), “recriando um ambiente 

embrionário” no tecido adulto danificado, melhorando os resultados clínicos (Petite et al, 2000). 

 

 

3. ENGENHARIA DE TECIDO ÓSSEO 

 

A Engenharia de Tecidos emergiu como uma promissora alternativa buscando soluções para as 

limitações existentes como os enxertos autólogos e/ou heterólogos para o tratamento de mau 

funcionamento ou reparo de partes danificadas dos tecidos ou órgãos. A Engenharia de tecidos combina 

células precurssoras provenientes do paciente, matrizes suportes e moléculas bioativas (Langer &amp;amp; 

Vacanti, 1993), que no tecido ósseo devem induzir a osteogênese. Aplica os princípios e métodos da 

engenharia e ciências da vida dirigindo a compreensão fundamental da relação estrutura-função nos 

tecidos normais ou patológicos de mamíferos e no desenvolvimento de substitutos biológicos que 

restaurem, mantenham ou melhorem as funções teciduais (Nerem, 1992; Langer &amp;amp; Vacanti 1993).  

Desde o advento da engenharia de tecido, o tecido ósseo tem despertado particular interesse, 

uma vez que possui grande capacidade regenerativa (Bessa et al, 2008, part II). 

O biomaterial utilizado para regeneração óssea deve possuir um gama de características 

semelhantes ao osso como, preencher ou servir de suporte para o tecido danificado, ser osteoindutor, 

osteocondutor, biodegradável, permitindo boa osteointegração (Albrektsson &amp;amp; Johansson, 2001; 

Shishatskaya et al, 2006). Segundo Verti (1992) biodegradação refere-se a um agente biológico (enzima, 

microorganismo ou célula) responsáveis pela degradação e dispersão in vivo. A biocompatibilidade pode 

ser definida como a capacidade do material ter uma resposta apropriada numa aplicação específica, com 

o mínimo de reações alérgicas, inflamatórias ou tóxicas, quando em contacto com os tecidos vivos ou 

fluidos orgânicos, compreendendo as interações dos tecidos e fluidos, incluindo sangue, com um 

material (Williams, 2003).  



23 

 

Osteointegração é um termo definido como o contato direto (em nível microscópico) entre o 

tecido ósseo vivo e o implante, sem o desenvolvimento de tecido fibroso entre eles. Deve-se ter em 

mente importantes termos citados em literatura como a osteoindução e osteocondução. Osteoindução é 

o termo utilizado quando células osteoprogenitoras são estimuladas a se diferenciar, induzindo 

osteogênese (Wilson-Hench, 1987). Osteocondução é o termo utilizado quando uma determinada 

superfície tem um ambiente adequado para o crescimento ósseo (Brånemark et al, 1977; Albrektsson, et 

al, 1981).   

Os arcabouços utilizados na engenharia de tecidos buscam mimetizar as funções da matriz 

extracelular natural. O primeiro papel dos arcabouços é servir de suporte para adesão celular, facilitando 

a localização e liberação de células quando estas são implantadas, consequentemente, propiciando um 

suporte mecânico adequado para o crescimento do novo tecido com  suas funções apropriadas (Kim et 

al., 2001; Lanza et al, 2000).  

 Os requerimentos estruturais e mecânicos dos suportes para a engenharia de tecidos e os pré-

requisitos para a fabricação dos suportes têm sido avaliados. Ênfase especial é dada ao grupo de técnicas 

com controle computadorizado, fabricação sólida com forma livre (SFF), também conhecida como 

prototipagem rápida (RP), técnicas que têm significante vantagem sobre as convencionais, baseadas em 

métodos de fabricação manual (Leong, 2003). 

Para o sucesso do suportes, estes devem apresentar as seguintes característica:  uma apropriada 

macroestrutura para promover a proliferação celular e a produção de matriz específica ao tecido; uma 

alta porosidade na superfície, com tamanho de poro adequado para permitir o crescimento e 

regeneração tecidual  evitando a oclusão do poro; apropriada morfologia de superfície e propriedades 

físico-químicas para permitir sinalização intracelular e o recrutamento de células; o material ainda deve 

apresentar apropriada taxa e degradação, com produtos atóxicos para células (Leong, 2003;  Yeong et al, 

2004). 

 A sinterização seletiva a laser (SLS) é um tipo de prototipagem rápida com emprego de laser de 

gás carbônico (CO2) para sinterização seletiva do pó de polímero ou compósito (polímero/cerâmico, 

metal multifásico) para formar camadas de material. O feixe de laser é direcionado diretamente na 

camada de pó através de um sistema de esquadrinhamento preciso a laser. As fusões de camadas do 

material são fixadas umas sobre as outras criando o objeto tridimensional. Durante a fabricação, o 

objeto é suportado e encaixado pelo pó circunvizinho não processado e precisa ser extraído das camadas 

de pó após a fabricação. Devido ao pó ser sujeito a uma baixa força de compactação durante a sua 



24 

 

deposição para formar novas camadas, os objetos fabricados via SLS são usualmente porosos. A 

porosidade dos dispositivos fabricados via SLS pode ser controlada através do ajuste dos parâmetros do 

processo SLS (Leong, 2003; Williams, 2005), granulometria do material e projeto mecânico dos poros em 

três dimensões com uma concepção biomimética (Das, 2003; Williams, 2005). 

 Matrizes colagênicas tri-dimensionais têm sido outra opção para Engenharia de Tecidos. A partir 

de uma solução contendo colágeno, aplica-se a técnica de freeze-dryer, obtendo-se uma matriz 

colagênica tri-dimensional, poros interconectados e de tamanho controlado (O’Brien et al,  2004). As 

propriedades dessas matrizes colagênicas podem ser melhoradas adicionando-se compostos de fosfato 

de cálcio, como a hidroxiapatita (HA),  ambos apresentando capacidade osteocondutivas (Al-Munajjed et 

al, 2009). 

Uma variedade de biomateriais tem sido utilizados como suportes osteocondutivos em cirurgias 

ortopédicas, entre eles, destacam-se os suportes inorgânicos como hidroxiapatita (Kong et al, 2007), e os 

polímeros (Sun et al, 2004; Shi et al, 2007), sendo estes naturais como colágeno ou sintéticos como PHB, 

PCL e PLGA entre outros (Lucchesi et al, 2009; Qian et al, 2009). Para melhorar a qualidade de resposta 

tecidual e celular, uma série de fatores de crescimento, proteínas osteoindutivas e até mesmo DNA, têm 

sido utilizados, gerando os compósitos.  

 

3.1 POLÍMEROS  

Nos últimos 20 anos, a pesquisa no campo dos polímeros, tem buscado o desenvolvimento  de 

novos métodos para se obterem materiais de origem biológica ou sintéticas, altamente compatíveis, 

capazes de melhorar a interação com os tecidos (Selfton, 2002; Netti et al, 2002). Junto à 

biocompatibilidade, um material utilizado como prótese, dispositivo biomédico ou suporte para 

engenharia de tecidos deve possuir um complexo arranjo biofísico, estrutural e propriedades biológicas 

compatíveis com os tecidos. Além disto, um biomaterial ideal para substituir defeitos no tecido, deve ser 

capaz de reproduzir suas funções biofísicas e biológicas (Netti et al, 2002). 

É fundamental que o biomaterial mantenha suas propriedades mecânicas, enquanto o novo 

tecido se regenera, suportando-o de modo adequado. Se por um lado, o material for pouco resistente, 

pode se obter substitutos inadequados. Por outro lado, se o material tiver resistência muito superior ao 

do tecido, pode-se causar tensão nas bordas do implante podendo resultar em fragilidade do osso. 



25 

 

Consequentemente, o biomaterial deve resistir aos procedimentos de esterilização e deve ter uma vida 

útil longa (Seal et al, 2001). 

A biointegração ideal tem sido esperada em implantes artificiais. Isto implica no fenômeno que 

ocorre na interface entre o implante e o novo tecido, não induzindo nenhum efeito deletério como 

resposta inflamatória intensa ou formação de tecido fibroso. Conseqüentemente, boas propriedades 

para interação celular na superfície do biomaterial são de grande importância para serem utilizados 

como implantes. 

Isto significa que estes materiais devem possuir propriedades e funções semelhantes as do 

tecido local (Sodhi, 1996). Como todos os materiais implantados no organismo, os polímeros destinados 

para a regeneração óssea devem ser biocompatíveis, moldáveis ou polimerizados in situ para assegurar 

um bom ajuste na região do defeito. Como características essenciais, devem suportar a adesão, 

crescimento e diferenciação celular, promover a rápida difusão de metabólitos, catabólitos e os resíduos 

gerados (Peter et al, 1998). 

Polímeros biorreabsorvíveis têm sido amplamente utilizados como suportes em engenharia de 

tecidos para direcionar o crescimento e diferenciação de células específicas (Patrick et al., 1998). O uso 

de materiais poliméricos em aplicações na área biomédica é um campo de pesquisa relativamente novo, 

em contínuo crescimento e para qual os profissionais de diversas áreas de conhecimento unem seus 

esforços para encontrar soluções de problemas previamente sem resposta (Williams, 1987; Hench, 

1998). 

No Brasil têm-se verificado um crescimento constante no número de trabalhos envolvendo 

polímeros com aplicações biomédicas. Vários pesquisadores vêm estudando os polímeros 

biorreasorvíveis in vitro e sua interação in vivo (Lucchesi et al, 2009; Messias et al, 2009; Lucchesi et al, 

2007; Silva et al, 2006; Pereira et al, 2006; Rezende et al, 2005; Barbanti et al, 2004; Marreco et al, 2004; 

Scapin et al, 2003; Luciano et al, 2002; Zoppi, et al, 2001; Ferreira et al, 2001; Duek et al, 1999), além dos 

polímeros de origem natural como as matrizes colagênicas (Goissis et al, 2003;  Sena et al, 2004), 

quitosana, etc. 

 
3.1.1 POLÍMEROS SINTÉTICOS: PHB, PCL e PLGA. 

Os ensaios com emprego de polímeros in vitro são estratégias fundamentais para o 

desenvolvimento no campo da engenharia de tecidos (Tormala et al, 1993). Dois campos em particular 

têm prosperado: a associação de fatores osteo-condutivos com o material implantado e a interação de 



26 

 

células tronco osteogênicas com estes materiais. Em ambos os campos, um entendimento dos 

fenômenos de adesão celular e em particular, das expressões de proteínas envolvidas na adesão de 

osteoblastos com os biomateriais é de crucial importância na manutenção da estrutura tecidual, 

cicatrização, resposta imune, e também na interação do tecido com os biomateriais (Anselme, 2002). 

Dentre os polímeros sintéticos, o poli(ácido lático-co-ácido glicólico) (PLGA) está entre alguns dos 

aprovados para o uso clínico em seres humanos pelo Food and Drugs Admnistration (FDA). Estes 

polímeros podem ser facilmente processados dentro da configuração desejada e suas propriedades 

físicas, químicas, mecânicas e sua degradabilidade, podem ser manipuladas para atender uma 

necessidade em particular.  

O PLGA é conhecido por ser um polímero biocompatível e biorreabsorvível se degradando 

através de uma simples hidrólise em ácido láctico e ácido glicólico, sendo estes produtos eliminados do 

corpo através de processos metabólicos normais (Göpferich, 1996). Sua taxa de degradação pode variar 

desde algumas semanas até anos, simplesmente variando o percentual de copolímeros de ácido lático 

para glicólico (Mikos et al, 1993), uma vez que estudos demonstraram que o poli(ácido lático) puro 

apresenta um longo tempo de degradação in vitro (Duek et al, 1999). A biocompatibilidade do PLGA 

também tem sido demonstrada em vários tecidos biológicos (Rezende et al, 2005). Porém, apesar de 

pinos do copolímero poli(ácido lático-co-ácido glicólico) ter mostrado bons resultados, nas interações 

células/tecido, estes materiais, não possuem as mesmas propriedades mecânicas que o osso e não 

podem ser implantados por período de tempo prolongado (Seal et al, 2001).  

Outro polímero que vêm sendo amplamente usado nos últimos 30 anos para a produção de fios 

de sutura, sistemas de liberação controlada de fármacos e atualmente está sendo explorado para 

substituição de enxerto de osso, é a Poli(caprolactona) (PCL) (Heath et al, 2002). Este polímero chamou a 

atenção devido a sua alta biodegradabilidade, biocompatibilidade e boas propriedades mecânicas (Cretu 

et al, 2003). As blendas poliméricas de PCL, assim denominadas por serem obtidas da mistura física de 

dois ou mais tipos de polímeros, vem sendo investigadas, pois podem melhorar as propriedades físicas e 

mecânicas quando comparadas aos polímeros puros (Park et al, 1992).  

Algumas blendas, incluindo polímero sintético e/ou polímero biológico (por exemplo, colágeno), 

têm sido preparadas com a finalidade de melhorar a biocompatibilidade do primeiro (Giusti et al, 1994). 

Em geral, a preparação de blendas tem sido realizada com o objetivo principal de controlar a velocidade 

de degradação de polímeros biodegradáveis. O tempo de degradação de um polímero biodegradável 

para aplicações biomédicas pode variar de meses a anos, dependendo dos balanços 



27 

 

hidrofílico/hidrofóbico e amorfo/cristalino. Estes balanços podem ser controlados em função da 

quantidade e do tipo de constituintes usados na preparação de uma blenda (Park et al, 1992). 

 Dentre as vantagens dos polímeros biorreabsorvíveis, dependendo dos seus componentes, 

podem-se obter moldes com rigidez suficiente, oferecendo suporte mecânico por um período de tempo 

adequado e permitindo a consolidação óssea, até que se inicie o processo de degradação do molde. 

Dentre os polímeros que apresentam vantagens, como termoplasticidade, biocompatibilidade e 

biodegradabilidade, destaca-se o poli (3-hidroxibutirato) (PHB) e seus copolímeros, poli(hidroxibutirato-

co-hidroxivalerato) (PHBV) (Ferreira, 2001). O PHB e seus copolímeros randômicos contendo unidades do 

3-hidroxibutirato e 3-hidroxivalerato (FIG.1) têm sido produzidos a partir de bactérias Alcaligenes 

eutrophus  [Hankermeyer &amp;amp; Tjeerdema, 1999]. 

 

 

 

 

 

 

 

 

 

 

 
Figura 1 – Na presença de água, as ligações ésteres presentes nestes polímeros, são rompidas, 

ocasionando a quebra da quebra da cadeia, gerando em uma das porções carbóxi terminal e hidróxi 

terminal. 

 

O PHB é um polímero altamente cristalino, tendo boa biocompatibilidade, porque seus derivados 

são produtos do metabolismo celular, estando presentes no sangue e tecidos. Entretanto, devido ao fato 

de ser quebradiço e ter baixa resistência mecânica, sua aplicação é limitada. Embora exista uma 

diversidade de polímeros conhecidos, poucos têm sido investigados como o copolímero 

polihidroxibutirato-co-hidroxivalerato (PHBV) (Volova et al, 2003).  

No entanto os poliésteres biorreabsorvíveis como o PHB e seus derivados, são pobres no que diz 

respeito à interação célula-matriz. Os PHBs são biomateriais hidrofóbicos (Ferreira et al, 2002; Hasirci et 



28 

 

al,2003)  apresentando ângulo de contato por volta de 80
o
 , porém a maior parte das células exibem boa 

adesão celular sobre superfície com ângulo de contato abaixo de 60
o
 (Yamaguchi et al, 2004). Ferreira et 

al. (2002), relatam que o PHBV é polímero com características hidrofóbicas, apresentando lenta adesão 

celular. A adesão celular é quesito essencial para tal finalidade e muitas são as opções disponíveis na 

engenharia de materiais para incrementar a adesão tais como o recobrimento com polímeros da matriz, 

enxertos na superfície e o tratamento por plasma (van Kooten, 2004). 

 
3.2 TRATAMENTO DE SUPERFÍCIES 

 

Tem-se demonstrado que modificações químicas na superfície dos materiais têm um importante 

papel na adesão e crescimento, proliferação e diferenciação celular além de propiciar que células 

diferenciadas possam depositar e remodelar a matriz extracelular depositada (Dalby et al, 2002). Isto 

indica que se deve dar atenção tanto à estrutura 3D polimérica e também ao tratamento de suas 

superfícies e/ou incorporar elementos bioativos capazes de influenciar o comportamento celular (Seal et 

al, 2001). 

 Dentre os tratamentos de superfície, aquele realizado com plasma é particularmente versátil 

pois a modificação é restrita ao topo da superfície, sem comprometer as propriedades do material como 

um todo (Chan, 1993). O tratamento por plasma pode ser usado para modificar a superfície do polímero 

de maneira não específica por mudanças na molhabilidade ou mais especificamente, introduzindo-se 

uma variedade de grupos funcionais dependendo do tipo de gás utilizado (Keen et al, 2006). Além disso, 

o tratamento por plasma torna a superfície estéril, podendo ser aplicado em dispositivos biomédicos, 

instrumentos cirúrgicos, engenharia de tecidos e aplicações clínicas. Estudos mostram que o tratamento 

por plasma pode destruir microorganismos, matando bactérias e vírus, esterilizando o material, 

representando mais uma vantagem (Chu et al, 2002). 

 Um grande número de pesquisadores tem investigado o tratamento por plasma para a 

modificação da superfície de polímeros como o PHBV.  Kose e colaboradores (2003) modificaram as 

características químicas e físicas da superfície por plasma de oxigênio e verificaram que esse tratamento  

aumentou a afinidade das células, as quais cresceram sobre o material, proliferaram e se diferenciaram, 

dando início a produção de uma matriz.  Langowski &amp;amp; Uhrich, (2005), estudaram a modificação do PHBV 

por plasma de oxigênio, resultando num aumento da hidrofilicidade do material.  Wan et al, (2005), 

melhoraram a hidrofilicidade da superfície do PHBV através da modificação por plasma de oxigênio, 



29 

 

mostrando que o crescimento das células mesenquimais foi melhor na superfície tratada. Keen et al, 

2006, utilizaram plasma de amônia e aminólise etilenodianima, observando que o tratamento por 

plasma acrescentou uma quantidade maior de grupos amina. Lucchesi et al (2008) trataram a superfície 

de membranas de PHBV com plasma dos gases oxigênio e nitrogênio, demonstrando uma alteração no 

comportamento de adesão de células Vero.  

 



30 

 

II. OBJETIVOS 

 

 

1) Avaliar o comportamento de osteoblasto-like proveniente de calota craniana de ratos Wistar sobre 

suportes de PCL/PLGA. 

 

2) Avaliar o comportamento in vitro de osteoblastos-like provenientes de calota craniana de coelhos 

New Zealand sobre arcabouços de PHB tri-dimensionais obtidos por prototipagem rápida e 

modificados por plasma de nitrogênio e oxigenio. 

 

3) Avaliar a interação polímero/célula/tecido in vivo após implante de arcabouços de PHB tri-

dimensionais obtidos por prototipagem rápida e modificados por plasma de nitrogênio e oxigenio, 

com o cultivo prévio de osteoblasto-like provenientes de calota craniana de coelhos New Zealand. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



31 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CAPÍTULO 2 

  



32 

 

 



33 

 



34 

 



35 

 



36 

 



37 

 



38 

 



39 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CAPÍTULO 3 



40 

 

RAPID PROTOTYPING OF POLY(HYDROXYBUTYRATE) SCAFFOLDS TREATED BY 

PLASMA TO SUPPORT OSTEOBLASTIC CELLS FROM RABBIT CALVARIA.  

 

Carolina Lucchesi
1,2

, Ricardo Z Lorenzon
1
, Betina M P Ferreira

1
, Marcelo F Oliveira

3
, Izaque A Maia

3
, 

Jorge VL da Silva
3
,Eliana A R Duek

1
, Paulo P Joazeiro

2*
. 

 

1. Laboratory of Biomaterials, Center of Medical Science and Health, Pontifical 

Catholic University of Sao Paulo, PUC/SP, SP, Brazil. 

2. Department of Histology and Embryology, Institute of Biology, State University of 

Campinas (UNICAMP), Campinas, SP, Brazil. 

3. Center of Information TechnologyRenato Archer, CTI, Campinas, SP, Brazil. 

*
pjoaz@unicamp.br 

 

ABSTRACT 

 

The complexity of bone into three dimensional (3D) in vitro models remains one of the most 

important challenges in the field of the tissue engineering. The models should faithfully mimic these 

tissues, resembling their organization, their mechanical properties and their physiological response to 

different stimuli. Indeed, the development and the optimization of novel culture systems may be necessary 

to face the next questions of bone physiology. For the new therapeutic strategy, it is indispensable to 

provide cells with a local environment that enhances and regulates their proliferation and differentiation 

for cell-based tissue regeneration. Biomaterial technology plays an important role in the creation of this 

cell environment. In this work three dimensional PHB scaffolds were obtained by rapid prototyping. Cells 

obtained from rabbit calvaria were culture on the scaffold 3D PHB scaffolds. The cells response were 

evaluated by MTT test, Sirius Red and SEM. The PHB showed good cells viability with no cytotoxic 

effects with or without treatment. The physical-chemical modifications on the samples caused by nitrogen 

plasma treatment improve cell attachment. The samples allowed improve the synthesis of type I collagen 

as one of the characteristics of osteoblast cell. The polymer PHB meets the requirements to act as scaffold 

for Tissue Engineering by being biocompatible, support growth and cell organization and by having its 

degradation products non-toxics to the cells.  The selective laser sintering has been a good technical to 

obtain 3D scaffolds for Tissue Engineering. 

 

Key-words: Poly(hydroxybutyrate) (PHB), Tissue engineering, Osteoblast.  

mailto:pjoaz@unicamp.br


41 

 

INTRODUCTION 

 

Bone fracture treatment is a widespread clinical practice and about 50% of these treatments need 

surgical intervention (PRAEMER, 1992). Along with the surgery, problems for the restoration of the 

mechanical integrity of the tissue and the establishment of the continuity of skeleton may appear (MA, 

2001). Tissue engineering, however, appears as the most viable alternative for the restoration of the 

skeleton continuity and the bone fixation (FLEMING, 2000). 

 The concept of Tissue Engineering is based on a cell/polymer system in which a bioresorbable 

polymer acts, for a period of time, as a substrate or scaffold to promote tissue formation (PETER, 1998). 

Most of bioresorbable implants are of the class of aliphatic polyesters derived from the ?-hydroxy acids 

family (NEBE, 2001). Other family that is widely studied is that of polyhidroxyalkanoates, which are 

polyesters accumulated by bacteria as a store of carbon and energy (REDDY, 2003).  

 Poly(3-polyhidrxybutyrate), PHB, is an example of polyhydroxyalkanoates polyesters family, 

being produced by bacterial fermentation. When deposited in the environment this biomaterial suffers the 

action of aerobic microorganisms, being completely degraded into CO2 and H2O. PHB is a bioresorbable 

polymer, therefore it is degraded by hydrolyses, generating products that are absorbed by the organism 

(KOSE et al., 2003). It was first discovered in Bacillus megaterium, in 1925, by Lemoigne at the Institute 

Pasteur of Paris. Since then, investigations have revealed its occurrence in a large number of bacteria and 

algae (BARHAM, 1990). 

 Due the properties as biodegradability, biocompatibility, optical activity, piezoelectricity and non-

toxicity, PHB has been studied for a variety of medical applications such as controlled drug-release 

system (POUTON &amp;amp; AKHTAR, 1996), surgical sutures, wound healing, in orthopedics (HOCKING, 

1994) and as pericardium substitute (LANGER &amp;amp; VACANTI, 1995). 

In last years it has been studied in Tissue Engineering in the form of porous substrate (DOYLE et 

al., 1996; HAZARI et al., 1999). The polymer PHB meets the requirements to act as scaffold for Tissue 

Engineering by being biocompatible, support growth and cell organization and by having its degradation 

products non-toxics to the cells (ZHIJIANG, 2006).   

 There is an advantage to use this polymer, it is coming from the Brazilian industry, PHB 

Industrial, which produces the polymer to about U$ 5.00/Kg in installation of 50t/year. That cost is 

significantly lower than the cost of the material from the international competitor, because there is 

technology in the production of derived substances from sugar-cane, raw material abundant in Brazil. 

Moreover, the cost of the polymer is also lower when compared to other bioresorbable polymers with 



42 

 

applications in the biomedical field, such as poly(L-lactic acid), poly(glycolic acid) and poly(p-

dioxanone). 

 Shishatskaya and Volova (2004) studied the cytotoxics effects of PHB and PHBV films in vitro. 

The authors showed that the materials studied have no cytotoxic effects on fibroblastic NIH 3T3 cells. The 

polymer was also studied in vivo. Other similar work developed by the group, surgical sutures made of 

PHB and PHBV were implanted in the muscles of Wistar rats, obtaining inflammatory responses similar 

to the one obtained with silk yarn and lower than the response obtained with catgut suture 

(SHISHATSKAYA et al., 2004). Malm et al. (1992) used PHB to correct defects of the atrial septum in 

calf. Twelve months after the implant, no polymer material was identified, but by polarized light 

microscopy, small particles of the polymer with a persistent foreign body reaction could be observed. 

 Most studies involving the PHAs as biomedical devices give attention to the copolymer PHBV. 

Due to PHB high level of cristalinity, there are difficulties in the process of obtaining devices with this 

polymer. However, by the technique employed in this work, the rapid prototyping by Selecting Laser 

Sintering (SLS) showed better results with PHB than with its copolymer poly(hydroxybutyrate-co-

hydroxyvalerate) (PHBV), which led us to use the PHB in our studies. 

 The characteristics of Tissue Engineering scaffolds are major concerns in the quest to fabricate 

ideal scaffolds. The solid freeform (SFF), also known as rapid prototyping, technologies which are fast 

becoming the techniques of choice for scaffold fabrication with the potential to overcome the limitations 

of conventional manual-based fabrication techniques. SFF-fabricated scaffolds have been found to be able 

to address most, if not all the macro- and microarchitectural requirements for TE applications as pore size, 

porosity and pore interconnectivity (Leong et al., 2003). 

Another issue is to establish of a stable interface between a biomaterial and the host environment 

is governed by both the material surface properties and the type and state of the biological tissue. The 

surface properties can be altered to suit a specific biomedical application, once the most of the polymers 

have hydrophobic surfaces, and most of the cells prefer to attach on hydrophilic surfaces (Yamaguchi et 

al, 2004). 

Plasma treatment can be used to modify a polymer surface in a nonspecific manner by changing 

the wettability or in a more specific manner by introducing a variety of functional groups depending on 

the type of gas used.  

In the present study, we treated tridimensional PHB scaffolds, obtaining by rapid prototyping, by 

oxygen and nitrogen plasma with the aim to evaluate the behavior of cell adhesion, proliferation and 

differentiation of osteoblasts cells from rabbit calvaria. 

  



43 

 

MATERIAL AND METHODS 

 

Scaffolds Preparation  

 

Three-dimensional PHB (Biocycle
®
, PHB Industrial S/A, Brazil) scaffolds were designed using a 

3-D solid modeling software, exported to a Sinterstation 2000TM machine (3D Systems, Valencia, CA), 

and constructed by Selective Laser Sintering processing (SLS). This PHB has a particle size distribution in 

the 10-100 ?m range. The circular scaffolds were produced with 6mm of diameter, 2mm of thickness and 

200-500 µm porous size. The samples were storage under vacuum until plasma treatment. 

 

Plasma treatment 

 

The plasma treatment was performed using a radio frequency Anatech LTD Ashing plasma 

apparatus. The plasma conditions employed in the treatment was PHB untreated; PHB treated by N2, 50W, 

150mTorr and 600s; PHB treated by O2, 100W, 300mTorr and 600s. The values of power, pressure, and 

time were chosen based on preliminary studies with PHBV (Lucchesi et al., 2008).  

 

Cell isolation, seeding and culture 

 

 Osteoblastic cells were obtained from 10 calvaria of young male adult (15 days old, 100–150 g) 

New Zealand rabbits, from university?s central animal house (PUC/SP-CCMB, Centro de Ciências 

Médicas e Biológicas, Sorocaba, SP, Brazil). Following euthanasia by cervical displacement, the calvaria 

were aseptically excised, cleaned with a soft tissue, and washed in Dulbecco?s modified Eagle?s  medium 

(DMEM) (Nutricell - Nutrientes Celulares, Campinas, SP, Brazil) containing 125 µg/mL gentamicin 

sulfate and amphotericin B (Sigma). This concentration of antibiotics was 5 times the normal amount used 

in cell culture and was used as a precautionary measure to avoid contamination during harvest. In sterile 

atmosphere, the calvaria were fragmented and submitted to enzymatic digestion for cellular isolation with 

1 mg/mL collagenase type 1A in DMEM (Sigma Chemical, St. Louis, MO) during 2 hours at 37°C. After 

this procedure, it was submitted to a three-stage centrifugation for 10 minutes at 1200 rpm (200 xg), and 

subsequently resuspended in DMEM containing 10% of fetal bovine serum (FBS) and antibiotic. After 

centrifugation, the pellet was resuspended in DMEM and cellular viability was quantified by staining with 

Tripan Blue vital stain (Sigma) in a Neubauer camera. Osteoblasts were seeded at a density of 

approximately 10
5
 cells/mL in culture flasks (TPP – Techno Plastic Products, Trasadigen, Switzerland) 



44 

 

containing DMEM, supplemented with 10% SFB (both Nutricell), 25 µg/mL gentamicin, 2.5 µg/mL 

amphotericin B, 10 mM ?-glycerol phosphate, 50 mg/mL L-ascorbic acid (Sigma) and 10 nM 

dexamethasone (all Sigma) to promote cells with osteoblastic phenotype, which were used in experiments 

after the third subculture. The flasks were incubated in a humidified incubator at 37°C (5% CO2/95% 

balanced air). When cells reached 80% of confluence, cell cultures were considered to have reached full 

growth and the cells were enzymatically lifted from the flask by using a 0.25% trypisin/EDTA solution 

and monitored daily with an inverted microscope, Eclipses TS 100 (Nikon, Tokyo, Japan). The culture 

medium was replaced tree times for week. 

 

Cell Adhesion and Viability Assays 

 

Identification of cell adhesion and viability on blends were carried out by performing the MTT 

assay, a modification of Mosmann?s (Mosmann, 1993)
 
 method, which was used for both cell adhesion 

and direct cell cytotoxicity assays (Santos Jr et al,  2001) Previously, the sterilized scaffolds were placed 

in a 96-well plate (Corning) with 100 µL of culture medium and incubated at 37°C for 24 h, according to 

Santos Jr., et al. (2005). After incubation, 2x10
5
 cells/mL in 100 µL DMEM supplemented with 10% FBS 

were added to the wells containing the membranes. The cells were cultured for 2 h and 24 h to allow cell 

adhesion and to conduct cell viability assays, respectively. After the cells were washed twice with 0.1 M 

phosphate-buffered saline (PBS), pH 7.4, at 37ºC and incubated with 100 µL DMEM, an MTT assay 

mixture [10 µL per well, containing 5mg/mL of 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyl-tetrazolium 

bromide - MTT, Sigma] was added to each well and incubated for 4 h at 37ºC. After 4h, 100 ?L of 

Dimethyl Sulphoxide (DMSO, Sigma) and 25 µL of Glycine/Sorensen buffered solution replaced the 

assay mixture in each well to dissolve the formazan crystals. Absorbance was quantified by a 

spectrophotometer at 570 nm, using a Elx-800-UV, Bio-Tek Instruments, USA. MTT is a colorless 

tetrazolium salt that forms a dark compound when oxidized by mitochondria, which is detected by 

spectrophotometer. For the viability assay, latex membranes embed in 1% phenol were used as positive 

control, and the culture plate (polystyrene) was used as negative control. For cell adhesion evaluation, 

Teflon dishes were used as negative control and the culture plate itself was used as positive control. The 

membranes were sterilized by UV irradiation for 30 min. Absorbance of all experimental conditions was 

also read. Comparison of continuous variables for all groups was done with ANOVA. When a significant 

difference was found (p &amp;lt;0.05), the groups were compared using Tukey?s test.  

 

 



45 

 

Colorimetric assay by Sirius Red 

 

Previously, the sterilized scaffolds were placed in a 96-well plate (Corning) with 100 µL of 

culture medium and incubated at 37°C for 7, 14 and 28 days. Sirius Red was purchased from Sigma 

(Sigma Chemical, St Louis, MO, US). The dye was dissolved in saturated aqueous picric acid at a 

concentration of 1 mg/mL. Bouin?s fluid were used to fix the samples and it was prepared by mixing 15 

mL saturated aqueous picric acid with 5 ml 35% formaldehyde and 1 mL glacial acetic acid. Although 

both reagents are stable for months, but we used freshly prepared dye reagent for each experiment and all 

chemicals were of analytical grade. Staining of extracellular matric (ECM) standards and cell layers, and 

quantification of the dye reaction. Solutions of the different ECM materials were dissolved in PBS at 0.1% 

(1 mg/mL), pipetted into 24-well plates, and air dried overnight in a sterile bench before fixation with 1 

mL/well Bouin?s fluid. The cells layers were extensively washed with PBS prior and after fixation. Then, 

the cells were stained by Sirius Red for 1 h under mild shaking on a microplate shaker. Thereafter, the dye 

solution was removed by suction and the stained cell layers washed with 0.01 N hydrochloric acid to 

remove all non-bound dye. The stained material was dissolved in 0.1 N sodium hydroxide using a 

microplate shaker for 30 min at room temperature. The dye solution was transferred to the plate reader and 

the optical density (OD) measured with a Biorad microplate reader 355 at 550 nm and the 0.1 N sodium 

hydroxide  was used as a blank (Tullberg &amp;amp; Jundt, 1999).  

 

Scanning Electron Microscopy (SEM)  

 

The scaffolds were sterilized by UV irradiation for 30 min and placed in 96-well plates. 

Approximately 2x10
5
 cells/mL osteoblastic cells in DMEM supplemented with 10% FBS were seeded in 

each well containing the membranes and cultured at 37
o
 C. After 6h, 1d, 2d, 7d, 14d and 21 days, the 

samples were fixed in a fixative solution prepared by dissolving 2.5% paraformaldehyde, 2.5% 

glutaraldehyde, 0.03% picric acid, 1% tannic acid in 0.1M cacodylate buffer and the same volume of 

DMEM for 1h at room temperature (RT), washed in 0.1M cacodylate buffer, post-fixed in 1% osmium 

tetroxide in water for 1h at RT in the dark, washed in water, dehydrated with ethanol, critical point dried 

[Balzers CDT 030] and coated with gold in a sputter coater [Balzers CDT 050]. The coated specimens 

were observed with a JEOL 5800 scanning electron microscope. 

 



46 

 

RESULTS AND DISCUSSION  

 

In this study we used osteoblastic cells from the calvaria of New Zealand rabbits, 15 days old, to 

evaluate the biocompatibility of the 3D PHB scaffolds, and to examine the possibility of its use in bone 

fractures recuperation processes.  

 

Cell Viability Assay 

 

 The statistical analyze of the viability assay showed difference among the samples and the 

controls, in which the positive control (phenol) presented a lower absorbance than the negative control 

(polystyrene) and all the samples in study presented a higher level of absorbance than the controls, 

positive and/or negative (p &amp;lt;0.05). There was no significant difference among the plasma treated and 

untreated samples (p &gt; 0.05) (Figure1). 

 

 

 

 

Figure 1 – Evaluation of cellular viability on three-dimensional devices of PHB. Quantification by MTT. 

 

 The PHB scaffolds, treated or not, showed to be less cytotoxic to the cells. There was no 

significant difference among the samples (p&gt;0.05). Since the polystyrene has good biocompatibility, our 

results indicate the good cytocompatibility of the material. 



47 

 

 A variety of polyesters has been used as biomedical device, with excellent results as its 

biocompatibility (SHIVE, 1997). PHB is among those polyesters with good results in vivo 

(SHISHATSKAYA et al., 2004) and in vitro (SHISHATSKAYA &amp;amp;VOLOVA, 2004). 

 Shamsuria et al. (2004) studied the cytotoxicity effects of hydroxyapatite (HA), of natural coral 

(NC) and of polyhidroxybutarate (PHB) with human osteoblastic cells CRL-1543. After 72h hours of 

incubation, PHB samples obtained the higher percentage of viable cells. Suwantong et al. (2007) studied 

the biocompatibility of mouse fibroblasts (L929) and Schwann cells (RT4-D6P2T) seeded on fiber mats of 

PHB and PHBV, not observing any negative response about the cytotoxicity of the materials. Our results 

are found in agreement with the literature, where PHB does not present any rate of toxicity. The plasma 

treatment in this study, independently of the gas used, did not alter the cytocompatibility of the material.   

 The cytocompatibility of the material is not the only requisite to consider it biocompatible, but it?s 

an important characteristic. MTT is reagent metabolized in the mitochondria, which allows us to say, that 

in the intracellular levels, the cells presented viables (MARQUES et al., 2005), which is also an important 

factor of the biocompatibility of the material. 

  

Cell adhesion 

 

In this study the statistical analyze of cell adhesion after 2 hours of incubation showed  significant 

differences among the positive (polystyrene plates) and negative controls (Teflon) and the samples, where 

the positive control (+) showed superior absorbance over the negative control (-)  and all the samples in 

study presented higher rates of absorbance than both controls (p &amp;lt;0.05). The untreated PHB scaffolds 

presented significant difference compared to the nitrogen plasma treated PHB, which presented the 

highest absorbance rate (p &amp;lt;0.05) (Figure 2).    

 

 

 

 

 

 

 

 

 

 



48 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 2 – Evaluation of cellular adhesion on three-dimensional devices of PHB. Quantification by MTT 

 

 The three-dimensional PHB scaffolds, treated or not, showed to allow the cell adhesion of 

osteoblasts even higher than the positive control. When we compare our samples, we observe that the 

nitrogen plasma treated samples presented better results and it was efficient to improve the cell adhesion 

of the material.  

 The cell adhesion phenomenon is of extreme importance to the biomaterials science. Once 

adhered on the material the cells can migrate and/or proliferate and exercise its physiological activities, 

such as the production of extracellular matrix. The adhesion is a consequence of the interaction of the 

proteins adsorbed on the substrate. These interactions involve electric charge, bridges of hydrogen and 

electrostatic forces. Other factors that modulate cell adhesion are the functional chemical groups present 

on the polymer surface, which is related to the hydrophilicity/hydrophibicity of the material surface (CHU 

et al., 2002). Surface rugosity is other important factor that can affect cell adhesion.  

Cell adhesion to polymeric substrates is one of the main points of tissue engineering, because the 

adhesive interactions control the cell physiology and also determines cell morphology (NEBE, 2001).   

According to some authors the hydrophilicity is a factor very important to the biomaterial 

cytocompatibility studies. Cell adhesion and growth on biomaterials surfaces are strongly influenced by 

the hydrophilicity/hydrophobicity balance, or wettability (TEZCANER et al, 2003; MA et al, 2003). 

The literature has also reported that there is no obvious correlation between hydrophilicity and cell 

behavior, as cell attachment; others demonstrated that the cells prefer to anchor on hydrophilic surfaces 



49 

 

(WAN et al, 2003). Another studies showed that the cells adhere, spread and grow more easily on 

moderate hydrophilic substrate than on hydrophobic or very hydrophilic substrate (TEZCANER et al, 

2003; MA et al, 2003; WAN et al, 2003). 

Although no topographical analyze of the materials used in this study was made, its widely 

described in the literature that the plasma treatment modifies physico-chemically the materials surface. 

Wan and collaborators could observe that the PLLA, when treated by ammonia plasma, had its 

hydrophilicity and energy surface level was improved . And such improvement provided a better quality 

of cell adhesion (WAN et al., 2003). Wang et al. (2005) cultivate osteoblasts (from bone marrow of 

rabbits and fibroblasts (L929) on PHB and PLA, having better results of cell adhesion for PHB. Lucchesi 

and collaborators (2007) studied Vero cells on PHBV samples treated by N2 and O2 plasma and showed 

that the plasma treated improved the cell attachment on the scaffolds. 

 

Collagen quantification assay by Sirius Red 

 

The biochemistry analyze of the quantification of collagen after 7 days of culture revealed that 

there was significant difference between the control (polystyrene plate),  the untreated samples and the 

samples treated by nitrogen plasma (p&lt;0.05). There was no statistically difference between untreated PHB 

and PHB treated by nitrogen. The PHB treated by oxygen showed similar absorbance compare to control 

(p&gt;0.05). After 14 days of culture the analyses revealed that there was significant difference among the 

control and scaffolds (p&lt;0.05). But, there was no difference between the PHB treated or untreated 

samples. After 28 days there was no significant difference among the samples (p&gt;0.05) (Figure 3).  

Besides the samples with cells, we also dyed samples of PHB without cell, treated and untreated, 

and we discount the value of their absorbance in the value of the other samples (with cells). It was made 

because of the possibility of the dye react with the biomaterial. 

 

 

 

 

 

 

 

 



50 

 

 

Figure 3: Quantification of collagen on three-dimensional devices of PHB after 7, 14 and 28 days of cell 

culture through the absorbance of Sirius red. 

 

As we could see by the graphics, the PHB scaffolds treated by plasma of O2 and N2, obtained a 

value of absorbance below the value obtained by the untreated PHB after the first 7 days of culture. With 

14 days of culture, the treated samples showed a significant improvement in the amount of collagen 

produced, obtaining values of absorbance closer to the ones obtained by the untreated PHB. 

Among the advantages of the method of coloring by Sirius red stands out the fact that the dye is 

highly specific for collagen proteins type I and III, in this case. The method is based on the selective 

connection of the Sirius red (acid dye) with collagen proteins (basic amino acids) and it has been applied 

to quantify collagen, not reacting with other components of the extracellular matrix, like fibronectin for 

example. This is important because fibronectin can be expressed in large quantities by pre-osteoblastic cell 

with poor differentiation and fast proliferation (TULLBERG-REITEN &amp;amp; JUNDT, 1999). 

Mineralization substances such as dexametasone, ascorbic acid and ?-glicerophosphate, present in 

the culture medium used in this study, can alter collagen synthesis after prolonged periods. Tullberg-

Reiten &amp;amp; Jundt  (1999) verified that the combination of ascorbic acid and ?-glicerophosphate stimulate the 

synthesis of collagen, and that dexametasone reduce the synthesis after 14 days of culture. The author also 

confirms that the ascorbic acid is considered an important inductor of synthesis of collagen, and that the 

ascorbic acid well as the ?-glicerophosphate is essential to the maturation of the bone mineralization.  



51 

 

In the present study the control samples received the same mineralization medium that the PHB 

samples received, however, the higher rate of absorbance obtained by the PHB samples demonstrated that 

the polymer not only allowed the osteoblasts to synthesize collagen type I and III, but also stimulate its 

synthesis. It was not possible to do an evaluation about the influence of each mineralization substance in 

the synthesis of collagen in our study, once the culture medium used had three substances together. Such 

fact, however, do not affect our work, once the amount of collagen produced by the cells cultured on PHB 

was superior than the amount produced by the ones cultured on the polystyrene plate as control.   

Collagen is the major component of the extracellular matrix and it represents about 90% of the 

organic substances present in the bone tissue. According to Tullberg-Reiten &amp;amp; Jundt (1999), places with 

large collagen deposition can represent places of synthesis of mature matrix before mineralization begins. 

Due to the material be three-dimensional and opaque, the visualization of these deposits was not possible 

by optical microscopy, but the quantitative analyze shows us evidence of its presence as both of its 

synthesis.  

Yet, collagen type I is the major extracellular component of the osteoblasts phenotype 

characterization (TULLBERG-REINERT &amp;amp; JUNDT, 1999). The high absorbance of the Sirius red 

evidences the phenotype of the osteoblastic cells in this study. The use of this method for the 

characterization of the cell phenotype has been described in the literature (SARUWATARI et al., 2005).  

For the statistical analyses we applied variance analyze (ANOVA) and Tukey?s test when the 

difference was significant (p &amp;lt;0.05) to compare the different treatment. 

 

Ultrastructural study  

 

 Through the scanning electron microscopy we could observe the PHB scaffold with cells and its 

different treatments, which allowed cell growth on all samples (Fig. 4-9). The scaffolds showed to be 

unstable during the analyses, which made the image obtaining harder. According to previous results 

obtained by the group, the PHB scaffolds showed rough structure suggesting higher porosity and low 

mechanical properties (Oliveira et al, 2007).  

 After 6 hours of culture, the cells adhered on PHB scaffolds treated and untreated by plasma, 

apparently similarly, with rounded morphology and not differing in quantity (Fig. 4). These aspects did 

not differ from the ones obtained after 24 hours of cell culture, although a huge amount of fibrilar material 

was observed on cells surface, that could suggested some matrix synthesis (Fig. 5). We could observe that 

after 48 hours of culture the presence of vesicles on cell surfaces was more frequent (Fig. 6). From day 7, 

there are evidences that the cells recover the entire scaffold, presenting structures similar to 



52 

 

microvilosities, being possibly, secretion of extracellular matrix (Fig. 7), specially at the treated samples 

by plasma (Fig. 7B-7C).  The samples after 14 days of culture, presented a high quantity of fibril material, 

seeing cell emitting cytoplasmatic projections. The fibril material on cell surfaces presented itself in 

fibrous form (Fig. 8).  After 21 days of culture, cells recovered the polymeric devices, presenting 

themselves close to one another and emitting cytoplasmatic projections to cellular groups more distant and 

granules that could suggesting minerals depositions since we used osteogenic medium (Fig. 9). 

 In general, the cells presented a rounded morphology, elongated or polygonal, with cytoplasmatic 

projections and particulate material on cell surface. The samples, independently of the treatment 

employed, presented themselves extremely irregular, which made the comparisons very difficult. 

However, it?s widely described in the literature that the plasma treatment, modify the surface properties of 

the material (KEEN et al., 2006) and that these surface properties influence the events of cell/substrate 

interaction. This is clear in many studies that show that these properties determine the type of biological 

molecule adsorbed (BOYAN et al., 1996). Other factors that influence in the material biocompatibility are 

surface rugosity, surface chemical groups and surface hydrophilicity. Lucchesi et al. (2008) observed that 

Vero cells, when cultured on PHBV membranes treated by oxygen or nitrogen plasma presented different 

behavior. Besides that, we should take into consideration the fact that different cellular types respond in 

different ways to different surfaces (COCHRAN et al., 1994). According to Bowers et al. (1992), cells 

similar to osteoblast, “osteoblast-like”, present a higher percentage of cell adhesion on substrates with 

rough surface, while fibroblasts adhere much better on flat surfaces. However, the PHB samples behaved 

themselves unstably to the electron beam, impairing not only the images analyses, but also its obtaining. 

By this technique, it was not possible to compare the plasma treated and untreated scaffolds.  

 The selective laser sintering has been a good technical to obtain 3D scaffolds for Tissue 

Engineering. For biomedical field it might be a great tool with high precision to mimetize bone 

architecture besides of the micro-fabrication. 

 

CONCLUSION 

 

The PHB showed good cells viability with no cytotoxic effects with or without treatment. The 

physical-chemical modifications on the samples caused by nitrogen plasma treatment improve cell 

attachment. The samples allowed improve the synthesis of type I collagen as one of the characteristics of 

osteoblast cell. The selective laser sintering has been a good technical to obtain 3D scaffolds for Tissue 

Engineering. 

 

ACKNOWLEDGEMENTS  



53 

 

 

The authors thank FAPESP process # (proc. 06/07147-3), Laboratório nacional de Luz Sincrotron (LNLS) 

and Centro de Tecnologia da Informação Renato Archer (CTI). 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



54 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 4: Scanning Electron Microscopy of PHB scaffold after 6 hours of cell culture. A) PHB; B) PHB 

O2; C) PHB N2.  



55 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 5: Scanning Electron Microscopy of PHB scaffold after 24 hours of cell culture. A) PHB; B) PHB 

O2; C) PHB N2.  



56 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 6: Scanning Electron Microscopy of PHB scaffold after 48 hours of cell culture. A) PHB; B) PHB 

O2; C) PHB N2.  



57 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 7: Scanning Electron Microscopy of PHB scaffold after 7days of cell culture. A) PHB; B) PHB 

O2; C) PHB N2.  



58 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 8: Scanning Electron Microscopy of PHB scaffold after 14 days of cell culture. A) PHB; B) PHB 

O2; C) PHB N2.  



59 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 9: Scanning Electron Microscopy of PHB scaffold after 21 days of cell culture. A) PHB; B) PHB 

O2; C) PHB N2.  

A 

B 

C 



60 

 

REFERENCES 

 
 

BARHAM, P. J. Physical properties of poly(hydroxybutyrate) and poly(hydroxybutyrate-hydroxyvalerate). DAWES, 

E.A. (ed). Novel Biodegradable Microbial Polyesters. Kluwer (1990) 694-697. 

 

BOWERS, K.T.; KELLER, J.C.; RANDOLPH, B.A.; WICK, D.G.; MICHAELS, C.M. Optimization of surface 

micromorphology for enhanced osteoblast responses in vitro. Int J Oral Maxillofac Implants, v.7, n.3, p. 302-10, 

1992. 

 

BOYAN, B.D.; HUMMERT, T.W.; DEAN, D.D.; SCHWARTZ, Z. Role of material surfaces in regulating bone and 

cartilage cell response. Biomaterials, v.17, p. 137-146, 1996. 

 

CHU, P.K.; CHEN, J.Y.; WANG, L.P.; HUANG, N.  Plasma-surface modification of biomaterials.  Mater Sci Eng 

Ver. v.36, p.143-206, 2002. 

 

COCHRAN, D.; SIMPSON, J.; WEBER, H.; BUSER, D. Attachment and growth of periodontal cells on smooth and 

rough titanium. Int J Oral Max Implant, v. 9, n. 3, p.  289-297, 1994. 

 

DOYLE, V.; PEARSON, R.; LEE, D.J. An investigation of the growth of human dermal fibroblasts on poly-L-lactic 

acid in vitro. J Mater Sci Mater Med, v. 7, pp. 381, 1996. 

 

FLEMING, J. E.; CORNELL, C. N.; MUSCHLER, G. F. Bone cells and matrices in orthopedic tissue engineering. 

Orthop. Clin. North. Am. v.31, p.357–74, 2000. 

 

HAZARI, A.; WIBERG, M.; JOHANSSON-RUDEN, G.; et al. A resorbable nerve conduit as an alternative to nerve 

autograft in nerve gap repair. British Journal of Pastic Surgery, v. 52, pp. 653-657, 1999. 

 

HOCKING, P.J.; ZIEGLER, J.B. Chemistry and Technology of Biodegradable Polymers. G. GRIFFIN, J.L. (editor). 

London: Chapman and Hall. p.48. 1994. 

 

KEEN, I.; BROOTA, O.; RINTOUL, L.; FREDERICKS, P.; TRAU, M.; GRONDAHL, L. Introducinh amine 

functionalities on a poly(3-hydroxybutirate-co-3-hydroxivalerate) surface: compring the use og ammonia plasma 

treatment and ethylenediamine aminolysis. Biomacromolecules, v.7, p.427,  2006. 

 

KOSE, G.T.; BER, S.; KORKUSUZ, F.; HASIRCI, V. Poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid)  based 

tissue engineering matrices. J Mater Sci Mater Med, v.14 p.121-126, 2003. 

 

LANGER, R.; VACANTI, J.P. Artificial organs. Sci Am. v.273, n.3, p.130-133, 1995.  

 

LEONG, K.F. et al. Solid freeform fabrication of tree-dimensional scaffolds for engineering replacement tissue and 

organs. Biomaterials, v.24, p.2363-2378, 2003. 

 

LUCCHESI. C.; FERREIRA, B.M.; DUEK, E.A.; SANTOS JR, A.R.; JOAZEIRO, P.P. Increased response of Vero 

cells to PHBV matrices treated by plasma. J Mater Sci Mater Med, v.19, n.2, p.3725-3730, 2008. 

 

MA, Z.; GAO, C.; GONG, Y. &amp;amp; SHEN, J. Chondrocyte behaviors on poly-L-lactic acid (PLLA) membranes 

containing hydroxyl, amide or carboxyl groups. Biomaterials, v.24, n.21, p.3725-3730, 2003. 

 

MALM, T.; BOWALD, S.; KARACAGIL, A.; BYLOCK, S. A.; BUSCH, C. A new biodegradable patch for closure 

of atrial septal defect. An experimental study. Scand. J. Thoracic Cardiovasc. Surg., v.1, p. 9–14, 1992. 

 



61 

 

MARQUES, A. P.; CRUZ, H.R.; COUTINHO, O.P.; REIS, R.L. Effect of starch-based biomaterials on the in vitro 

proliferation and viability of osteoblast-like cells. J Mater Sci Mate. Med, v.16, p.  833-842, 2005. 

 

MOSMANN, T. A rapid colorimetric assay of cellular growth and survival: Aplication to proliferation and 

cytotoxicity assays.  J. Immunol. Methods, v.65, p.55-63, 1983. 

 

NEBE, B. et al. Structural alterations os adhesion mediating components in cells cultured on poly-?-hydroxy butyric 

acid. Biomaterials. 22 (2001) 2425-2434. 

 

OLIVEIRA, M., MAIA, I.A., NORITOMI, P.Y., NARGI, G.C., SILVA, J.V.L., FERREIRA, B.M.P., DUEK, E.R. 

Construção de Scaffolds para engenharia tecidual utilizando prototipagem rápida Revista Matéria, v.12, n.2, p.373 – 

382, 2007. 

 

PRAEMER, A.; FURNER, S.; RICE, S. P. Musculoskeletal conditions in the United States. IL, USA: American 

Academy of Orthopaedic Surgeons. (1992). 

 

PETER, S.J., MILLER, M.J., YASKI, A.W. et al., Polymer concepts in tissue engineering. Journal of Biomedical 

Materials Research, v. 43, pp. 422-427, 1998. 

 

 

POUTON, C.W.; AKHTAR, S. Biosynthetic polyhydroxyalknoates and their potencial in drug delivery. Adv Drug 

Del Rev,  v.18, p.133-162,  1996. 

 

REDDY, C.S., GHAI, R., RASHIMI et al., Polyhydroxyalkanoates: an overview. Bioresource Technology, v. 87, pp. 

137-146, 2003. 

 

SANTOS Jr., A. R.; BARBANTI, S.H.; DUEK, E.A.R.; DOLDER, M.A.H.;  WADA, R.S.; WADA, M.L. Vero cell 

growth and differentiation on poly(L-lactic acid) membranes of different pore diameters.  Artif. Organs, v.25, p.7, 

2001. 

 

SANTOS JR, A.R.; FERREIRA, B.M.P.; DUEK, E.A.R.; DOLDER M.A.H.; WADA, M.L.F. Use of blends of 

bioabsorbable poly(L-lactic acid)/poly(hydroxybutyrate-co-hydroxyvalerate) as surface for Vero cells culture. Braz J 

Med Biol Res, v.38, p.1623-32, 2005. 

 

SARUWATARI , L.;  AITA,  H.;  BUTZ, F.; NAKAMURA, H.K.; OUYANG, J.; YANG, Y.; CHIOU, W.A.; 

OGAWA, T. Osteoblasts generate harder, stiffer, and more delamination-resistant mineralized tissue on titanium 

than on polystyrene, associated with distinct tissue micro- and ultrastructure. J Bone Miner Res., v.20, n.11, p.2002-

2016, 2005.  

 

SHAMSURIA, O.; FADILAH, A.S.; ASIAH, A.B.; RODIAH, M.R.; SUZINA, A.H.; SAMSUDIN, A.R. In vitro 

cytotoxicity evaluation of biomaterials on human osteoblast cells CRL-1543; hydroxyapatite, natural coral and 

polyhydroxybutarate. Med J Malaysi, v. 59, suppl B. p.174-175, 2004. 

 

SHISHATSKAYA, E.I.; VOLOVA, T.G. A comparative investigation of biodegradable polyhydroxyalkanoates 

films as matrices for in vitro cell culture. J Mater Sci Mater Med, v.15, p. 915-923, 2004. 

 

SHISHATSKAYA, E.I.; VOLOVA, T.G.; PUZYR, A.P.; MOGYLNAYA, O.A.; EFREMOV, S.N. Tissue response 

to the implantation of biodegradable polyhydroxyalkanoate suture. J Mater Sci Mater Med, v.15, p. 719-728, 2004. 

 

SHIVE, M.S.; ANDERSON, J.M. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug 

Deliv Rev, v.28, p.5-24, 1997. 

 

SUWANTONG, O.; WALEETORNCHEEPSAWAT, S.; SANCHAVANAKIT, N.; PAVASANT, P.; 

CHEEPSUNTHORN, P.; BUNAPRASERT, T.; SUPAPHOL, P. In vitro biocompatibility of electrospun poly(3-



62 

 

hydroxybutyrate) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) fiber mats. Int J Biol Macromol, v.40 p. 217–

223, 2007.   

 

TEZCANER, A.; BUGRA, K.; HASIRCI, V. Retinal pigment epithelium cell culture on surface modified poly 

(hydroxybutyrate – co – hydroxyvalerate) thin films. Biomaterials, 24, p.4573-4583, 2003. 

 

TULLBERG-REINERT, H. &amp;amp; JUNDT, G. In situ measurement of collagen synthesis by human bone cells with a 

Sirius Red-based colorimetric microassay: effects of transforming growth factor b2 and ascorbic acid 2-phosphate. 

Histochem Cell Biol, v.112, p.271–276, 1999. 

 

VOLOVA, T.; SHISHATSKAYA, E.; SABASTIANOV, V.; EFREMOV, S.; MOGILNAYA, O. Results of 

biomedical investigations of PHB and PHB/PHV fibers. Biochemical Eng J v.16, p.125, 2003. 

 

WAN Y, YANG J, YANG J, BEI J, WANG S. Cell adhesion on gaseous plasma modified poly-(L-lactide) surface 

under shear stress field. Biomaterials., v.24, n.21, p.3757-64, 2003. 

 

WANG, W.; YANG, F.; WU, O.; CHENG, Y. Effect of composition of poly(3-hydroxybutyrate-co-3-

hydroxyhexanoate) on growth of fibroblast and osteoblast.  Biomaterials, v.26, p. 755–761, 2005. 

 

YAMAGUCHI, M. et al. M. Surface modification of poly(L-lactic acid) affects initial cell attachment, cell 

morphology, and cell growth. J Artif Organs, v.7, p.187-193, 2004. 

 

ZHIJIANG, C. Biocompatibility and biodegradation of novel PHB porous substrates with controlled multi-pore size 

by emulsion templates method. J. Mater. Sci.: Mater. Med., v.17, p.1297-1303, 2006. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



63 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CAPÍTULO 4 

 



64 

 

 

OSTEOBLAST CELLS ON 3D PHB OBTAINED BY RAPID PROTYPING: IN 

VIVO STUDY 

Carolina Lucchesi
1,2

, Cíntia Cristina Santos
1
, Betina M P Ferreira

1
, Marcelo F Oliveira

3
, Izaque A Maia

3
, 

Jorge VL da Silva
3
,Eliana A R Duek

1
, Paulo P Joazeiro

2*
. 

1. Laboratory of Biomaterials, Center of Biomedical and Biological Sciences, Pontifical 

Catholic University of Sao Paulo, PUC/SP, SP, Brazil. 

2. Department of Histology and Embryology, Institute of Biology, State University of 

Campinas (UNICAMP), Campinas, SP, Brazil. 

3. Center of Research Renato Archer, CenPRA, Campinas, SP, Brazil. 

*pjoaz@unicamp.br  

 

 

ABSTRACT   

Controlling the differentiation of bone mesenchymal cells and providing tissue functions in 

engineered constructs before implantation are major challenges. Poly(hydroxybutyrate) (PHB) has good 

properties as biodegradability, biocompatibility, optical activity, piezoelectricity, non-toxicity and also it 

has been studied for a variety of medical applications. Here we evaluate the tissue interaction of 3D PHB 

scaffolds implant in rabbit calvaria. The scaffolds were obtained by rapid prototyping and some of the 

scaffolds were treated by nitrogen plasma. The PHB scaffolds had osteoblast cells culture prior implant in 

rabbit calvaria model at 7, 15, 30, 60 and 90days. Histological evaluation were used to investigated the 

response of the tissue to the three-dimensional environment provided by polymer and cells. The PHB 

porous scaffolds had higher amount of new bone area compared to scaffolds without cell culture and 

defect control area, suggesting that scaffold material and design combinations could be tailored to 

facilitate filling of bony defects.  

Key-words: Poly(hydroxybutyrate) (PHB); Bone; Calvaria; In vivo; Rapid Prototyping. 

 

INTRODUCTION  

The reconstruction of calvarial and maxillofacial bone defects caused by trauma, diseases, or 

congenital anomalies needs reliable reconstruction tools. The repair of three dimensional structurally 

complicated bone defects poses a challenge to implant design and manufacturing. The combination of 

computer tomography and rapid prototyping technology has offered solutions to this challenge (Chiarini et 

al, 2004; Choi &amp;amp; Cheung, 2005; Tuusa et al, 2008). 

The development and modification of orthopedic implants has taken place for many years in an 

effort to create an optimal interaction between the body and the implanted material. The goal of achieving 

an optimal bone-implant interface has been approached by the alteration of implant surface topography, 

mailto:pjoaz@unicamp.br


65 

 

chemistry, energy and charge as well as bulk material composition. Schmidt et al. (2001) defines an ideal 

bone implant material as having a biocompatible chemical composition to avoid adverse tissue reaction, 

excellent corrosion resistance in the physiologic milieu, acceptable strength, a high resistance to wear and 

a modulus of elasticity similar to that of bone to minimise bone resorption around the implant (Pearce et 

al, 2007).  

In order to determine whether a new material conforms to the requirements of biocompatibility 

and mechanical stability prior to clinical use, it must undergo rigorous testing under both initial in vitro 

and then in vivo conditions. However, in vitro characterization is not able to demonstrate the tissue 

response to materials, instead being confined to the response of individual cell lines or primary cells taken 

from animals. No in vitro cell culture system is able to produce loading that simulates the in vivo situation 

and currently very few ex vivo systems are able to approach such physiological loading (and usually only 

with small tissue samples (Davies et al., 2006). For these reasons animal models are essential for 

evaluating biocompatibility, tissue response and mechanical function of an orthopaedic  material prior to 

clinical use in the human (Pearce et al, 2007).  

Poly(hydroxybutyrate) (PHB) is known as a very rigid, highly crystalline, and hence slow 

degrading, but thermoplastic polymer (Gogolewski et al, 1993). It is thought to be useful for bone tissue-

engineering approaches due to the negligible acidification of surrounding tissue during degradation 

compared to other polyesters (Chen &amp;amp; Wang, 2002).  Porous scaffolds of PHB and co-polymers have 

mainly been revealed with good biocompatibility and they have been used for many medical applications 

(Zheng et al, 2003). 

 Another crucial characteristic is the geometry of a scaffold, such as the pore size, porosity, and  

pore interconnectivity, which can affect the diffusion of the nutrients, cell attachment, migration, and 

tissue ingrowths that are necessary for the bone formation process (Kim et al, 2008a). Others studies aim 

to evaluate the effect of implant surface modification on alteration of the bone-implant interaction (Kim et 

al, 2008b). In order to draw accurate conclusions regarding the effects of implant modification, we implant 

3D PHB scaffolds treated by N2 plasma with osteoblast cells as a purpose to filling out bone defects. 

    

 

METHODS 

Scaffolds Preparation  

Three-dimensional PHB (Biocycle
®
, PHB Industrial S/A, Brazil) scaffolds were designed using a 

3-D solid modeling software, exported to a Sinterstation 2000TM machine (3D Systems, Valencia, CA), 

and constructed by Selective Laser Sintering processing (SLS). This PHB has a particle size distribution at 

the 10-100 ?m range. The scaffolds were produced with 6mm of diameter, 2mm of thickness and 200-500 

µm porous size. The samples were storage under vacuum until plasma treatment. 

Plasma treatment 

The plasma treatment was performed using a radio frequency Anatech LTD Ashing plasma 

apparatus. The plasma conditions employed in the treatment was PHB untreated; PHB treated by N2, 50 

W, 150mTorr and 600s; PHB treated by O2, 100 W, 300mTorr and 600 s The values of power, pressure, 

and time were chosen based on preliminary studies with PHBV (Lucchesi et al, 2008).  



66 

 

Scanning Electron Microscopy (SEM) 

 

The blends were sterilized by UV irradiation for 30 min and placed in 96-well plates. 

Approximately 2x10
5
 cells/mL in DMEM medium supplemented with 10% FBS were seeded in each well 

containing the PHB scaffolds and cultured at 37
o
 C. After 24 hours, the samples were fixed in a fixative 

solution prepared by dissolving 2.5% paraformaldehyde, 2.5% glutaraldehyde, 0.03% picric acid, 1% 

tannic acid in 0.1M cacodylate buffer and the same volume of DMEN medium for 1h at room temperature 

(RT), washed in 0.1M cacodylate buffer, post-fixed in 1% osmium tetroxide in water for 1h at RT in the 

dark, washed in water, dehydrated with ethanol, critical point dried (Balzers CDT 030, Balzers Inc., Elgin, 

IL, USA) and coated with gold in a sputter coater (Balzers CDT 050, Balzers Inc., Elgin, IL, USA). The 

coated specimens were observed with a JEOL 5800 scanning electron microscope. 

 

Cell isolation, culture and seeding 

 

Osteoblastic cells were obtained from 10 calvaria of young male adult (15 days old, 230–280 g) 

New Zealand rabbits, from university?s central animal house (PUC/SP-CCMB, Centro de Ciências 

Médicas e Biológicas, Sorocaba, SP, Brazil). Following euthanasia by cervical displacement, the calvaria 

were aseptically excised, cleaned with a soft tissue, and washed in Dulbecco?s modified eagle?s medium 

(DMEM) (Nutricell - Nutrientes Celulares, Campinas, SP, Brazil) containing 150 ?g/ml gentamicin 

sulfate (Sigma Chemical, St. Louis, MO) and 15µg/ml Amphotericin B (Sigma). This concentration of 

antibiotic was 3 times the normal amount used in cell culture and was used to prevent contamination 

during harvest. In sterile atmosphere, the calvaria were fragmented and submitted to enzymatic digestion 

for cellular isolation in DMEM medium and 1mg/mL of collagenase type II (GIBCO, Invitrogen 

Corporation, Carlsbad, CA) during 2 hours at 37°C. After this procedure, it was submitted to a three-stage 

centrifugation for 10 minutes at 240 g force, and subsequently resuspended in DMEM medium containing 

10% of fetal bovine serum (FBS) and antibiotic. After centrifugation, the pellet was resuspended in 

DMEM medium and cellular viability was quantified by staining with Tripan Blue vital stain (Sigma) in a 

Neubauer camera. Osteoblasts were seeded at a density of approximately 10
5
 cells/ml in culture flasks 

(TPP-Techno Plastic Products, Trasadigen, Switzerland) containing DMEM medium, supplemented with 

10% FBS and 50 ?g/mL gentamicin, 10 mM ?-glycerol phosphate (Sigma), and 50 µg/mL L-ascorbic acid 

(Sigma) containing 100 nM dexamethasone (Sigma) to promote cells with osteoblastic phenotype, which 

were used in experiments at the third subculture. The flasks were incubated in a humidified incubator at 

37°C (5% CO2/balanced air). When cells reached 80% of confluence, cell cultures were considered to 

have reached full growth and the cells were enzymatically lifted from the flask by using a 625 mg/mL 

trypsin/EDTA (Nutricell) solution and monitored daily with an inverted microscope, Eclipse TS 100 

(Nikon, Tokyo, Japan). At the third subcultive 2x10
5
cells/ml were seemed in the PHB scaffold treated and 

untreated by plasma and it was kept for 24 hours at the same conditions for the implant procedures. 

Animal model  

 

The animal model used in this study was New Zealand rabbit (3 months age) with 2.5-3.0 Kg. The 

animals were obtained from University?s Central Animal House at Pontifícia Universidade Católica de 



67 

 

São Paulo, in Centro de Ciências Médicas e Biológicas de Sorocaba (PUC-SP/CCMB). The animals were 

kept in cages separately and received commercial food and water “ad libitum”. Rabbits are the most 

commonly used animals for medical research, being used in approximately 35% of musculoskeletal 

research studies (Neyt et al., 1998). International standards established regarding the species suitable for 

testing implantation of materials in bone, state that dogs, sheep, goats, pigs or rabbits are suitable. 

Although rabbit have a different microstructure from humans histologically (Wang et al., 1998), there are 

ethical implications of using companion animals for medical research. Rabbits are commonly used for 

screening implant materials prior to testing in a larger animal model (Pearce et al, 2007).  

  The experimental protocol used in this work is in agreement with both the standards of The 

American Society for Testing and Materials (ASTM F-981-93) and the Ethical Principles for Animal 

Experimentation adopted by the Brazilian Animal Experimentation Board (COBEA). It was also approved 

by the Research in Ethics Commission  from Vale do Paraíba University according to Ethics and 

Principles from  National and International Guidelines of research involving animals under protocol 

number A38/CEP/2008.  

 

Surgical procedure 

 

The rabbits were acclimated for 1 week before operation and monitored for general appearance, 

activity, excretion, and weight. Fifteen rabbits were used and were randomly shared in 5 groups, 

equivalent at the different times of implant of the scaffold (7, 15, 30, 60 and 90 days), and 3 rabbits were 

used for each time. They were implanted PHB scaffolds with different treatments in the same animal: 

PHB with cells, PHB without cells and PHB with cells and treated by Nitrogen plasma. Cylindrical 

implants are not recommended to be larger than 2mm in diameter and 6mm in length for rabbits 

(International Standard ISO 10993-6, 1994; Pearce 2007). 

 The animals were anesthetized with ketamine (50 mg/kg IM) and xylasine (5 mg/kg IM). After 

shaved and disinfecting the operative site, the periosteum was resected, and 4 defects site with 6 mm 

diameter each were provoked carefully by dental bar cooled (Beltec) with sterile saline solution. The 

craniotomy segment was removed and the damage to the underlying dura and superior sagittal sinus vein 

were avoided. The defect was rinsed with sterile saline thoroughly and bone fragments were washed out. 

Three defects were filling out with the scaffolds and one of them was kept without scaffold as a 

defect control. The design of the scaffolds implants follow above: Group 1 – Defect control, it was not 

filling out (G1); Group 2 – Defect filling out by PHB without cells (G2); Group 3 – Defect filling out by 

PHB with cells (G3). Group 4 - Defect filling out by PHB treated by nitrogen plasma with cells (G4). 

(Fig.1).  

The calvaria segments were removed carefully without disturbing the underlying dura-mater. The 

animals were harvested under pre-anesthesia by administration of Ketamine (50 mg/kg IM) and Xylazine 

(5 mg/kg IM), and euthanized with Sodium Pentobarbital (200mg/Kg IP). After that, the soft tissues were 

removed, and the skull was resected. The samples were kept in 4% formaldeide solution for histological 

procedures. 

 

 

 



68 

 

 

 

 

 

 

 

 

 

Figure 1: Design of the surgery at the rabbits. 1 - Control defect site; 2 - PHB implanted without cells; 3 - 

PHB implanted with cells; 4 - PHB treated by nitrogen plasma with cells. 

 

Histology 

The calvaria segments for histological examination were fixed in 4% buffered formalin (pH 7.4). 

The samples were decalcified in 10% EDTA solution and then they were dehydrated in a graded series of 

ethanol, and half of the samples were embedded in resin methylmethacrylate (Kit #14702231731, 

Historesin, Leica) and another half in paraffin (Histoseck, Merck). After polymerization, 3 ?m and 5 ?m 

sections respectively, they were cut from the center of the implants using a microtome RM2245 (Leica 

Reichert Jung, Nußloch, Germany). Light microscopic sections were stained with Toluidine Blue and 

Hematoxilin-Eosin, respectively. The samples were observed and evaluated by optical light microscope 

(Nikon, Eclipse E800, Tokyo, Japan). 

  

 

RESULTS 

 

Gross Analyses 

 

All 15 rabbits tolerated the anesthesia and the surgical procedures well and experienced no 

complications during the experimental period. Upon sacrifice, gross examination of the dissected 

specimens of the calvaria showed no difference between the PHB groups and the control group defects in 

terms of signs of inflammation and integrity of the healing wound. 

 

Ultrastructural analyses  

 

Through the scanning electron microscopy it was possible visualize the ustrastructural 

morphology of PHB scaffolds (Figure 2) and with cells attached after 24h (Figure 3).  We can observe 

http://www.leica-microsystems.com/Configurator/LMSSHOP.nsf/PC?openagent&amp;amp;product=Leica%20CONSUMABLES&amp;amp;sheet=HBUCONS&amp;amp;config=%202&amp;amp;optionset=o14


69 

 

clusters of cells attached in the PHB treated and untreated by plasma after 24 hours of culture in 

osteogenic medium. The cells adhered to the scaffolds and interact themselves showing cells agglomerate 

(Figure 3A-B). We could note some products on cells and scaffolds surface.  

 

Histological Analyses 

 

The healing of the defects in the control group was mainly by scar formation. There were a few 

bony islands scattered along the defect margins, which might have resulted from bone debris produced by 

drilling through bone. The healing of the PHB group produced a tissue regenerate with many blood 

vessels and cellular marrow spaces.  

At 7 days post-surgery all the PHB samples with and without cells showed fibrin network, 

mesenchymal cells, blood vessels (Figure 4), edema, cell proliferation with no significant inflammatory 

reaction, and at PHB N2 some cells showed osteoblast?s phenotype (Figure 4D). The defect control was 

noted large hemorrhage area, bone fragments, and some bone formation close to the edge of the defect 

(Figure 4E). 

 At 15 days post-surgery it was observed at all the samples with PHB, fibrous connective tissue, 

fibroblasts, blood vessels, and mesenchymal cells (Figure 5). At the defect control, it was observed fibrous 

connective tissue without bone formation (Figure 5A). At the PHB treated by N2, it was noted osteoblasts 

cells secreting bone matrix, collagen fibers and a slight inflammatory process (Figure 5D).  

 At 30 days post-surgery, it was observed fibrous connective tissue around all of the samples with 

PHB as fibroblasts, blood vessels and mesenchymal cells. It was presented osteoblasts around of the 

polymer and of the edges of the defect. Large amount of new bone formation almost cover the defect 

(Figure 6). The PHB without cells, it was showed osteoids and osteoblasts around of the polymer (Figure 

6C). PHB treated by N2, there was new bone tissue growing up from the edges of the defect toward to the 

polymer with the fibrous connective tissue, osteoids and osteoblasts (Figure 6D). The control defect area 

there was growth bone tissue near of the edges, and a thick layer of fibrous connective tissue, with no 

significant new bone formation (Figure 6A). 

 After 60 days post-surgery, the connective tissue around all of the PHB samples was slight. Blood 

vessels and mesenchymal cells condensed were presented with bone tissue growing up from the edges and 

absent inflammatory process. The mainly difference between the samples were that PHB with cells 

showed more of osteoids and osteoblast around the polymer than the other samples with new bone 

formation (Figure 7). The defect control area has shown bone tissue growing up from the edges, some 

osteoids and larger amount of connective tissue than PHB samples (Figure 7A-D).  

The 90 days PHB samples with cells tended to have more mature, trabecular bone whereas the 

PHB without cells samples had more bone tissue and less trabeculated chunks of bone. Although, statistics 

analyses were not made it to quantified. It was observed connective tissue, blood vessels, mesenchymal 

cells aggregated, osteoblasts-like and growth of bone tissue from the edges of the defect in all of the 

polymers. PHB treated by N2 and PHB with cells, we could observe osteocytes in the bone matrix and 

osteoblasts between bone fragments. The bone matrix showed some organizations and large amount of 

osteoblasts were observed (Figure 8B and 8C). The defect control was almost filling out by immature 

bone tissue (Figure 8A). 

 



70 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 2: Scanning electron microscopy of PHB scaffolds without cell culture. A) PHB without 

treatment; B) PHB treated by nitrogen plasma. 

A 

B 



71 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 3: Scanning electron microscopy of PHB scaffolds. A) PHB without treatment; B) PHB treated by 

nitrogen plasma. 

A 

B 



72 

 

 

 

 
 

 

Figure 4: Sections after 7 days of implant. All the PHB samples (P) showed mesenchymal cells (C), blood 

vessels (arrow), fibrin network (F) and edema. A) Control defect showing with hemorrhage area (H); B) 

PHB without cells; C) PHB with cells; D) PHB N2 with cells. Bar = 50µm. 



73 

 

 
 

 

Figure 5: Sections after 15 days of implant. The PHB samples with cells culture prior implant showed 

cells (C) in differentiation process around the polymer (P), blood vessels (arrow). A) Control defect 

showing with hemorrhage area (H) and edema; B) PHB without cells showed more cells of inflammatory 

process than the samples with cells culture prior implant; C) PHB with cells; D) PHB N2 with cells. Bar = 

50µm. 



74 

 

 
 

Figure 6: Sections after 30 days of implant. All of the samples with PHB (P) showed fibroblasts, blood 

vessels (arrow), fibrous tissue and cells (C). A) Control defect; B) PHB without cells showed a larger 

amount of connective tissue (T) than the other PHB samples; C) PHB with cells; D) PHB N2 with cells. 

Bar = 50µm. 



75 

 

 
 

Figure 7: Sections after 60 days of implant. The connective tissue around all of the PHB samples was 

slight. Blood vessels (arrow) and mesenchymal cells condensed (C) were presented with some osteoids 

(O), mainly in the samples with cell cultures prior implant. A) Control defect; B) PHB without cells; C) 

PHB with cells; D) PHB N2 with cells. Bar = 50µm. 



76 

 

 

 

Figure 8: Sections after 90 days of implant. A) Control defect with bone repair from the edges (E); B) 

PHB without cells; C) PHB with cells; D) PHB N2 with cells. Note the samples with cell culture prior 

implant there were more osteoids (O) than PHB without cells or the defect control area. All the samples 

(P) showed blood vessels (arrow), mesenchymal cells, osteoblast cells and connective tissue. Bar = 50µm. 



77 

 

 

 

DISCUSSION 

Bone defects are a significant clinical problem. These defects can be caused by inflammation, 

trauma, congenital malformation, diseases or oncological surgery (Mai et al, 2006). The available 

literature data suggest that both nonresorbable and resorbable polymers can be used for the preparation of 

the scaffolds for the treatment of bone defects (Hoffman et al, 2009; Jiya et al, 2009). 

The bioresorbable polymers should satisfied several biological requirements as the polymer do not 

induce foreign body reaction, was not be carcinogenic, mutagenesis or teratogenesis, did not cause 

allergies, hipersensibility ou toxicicity, even stimulate the complement system, it is a relevant importance 

(Orefice et al, 2006). However, is has been described in literature that ever material introduce in the body 

it will have some kind of reaction, in a large or smaller proportion. At this point all of the PHB samples 

used in this research were appropriated according to biological and technical requirements, which are in 

agreement with Gogolewski et al., 2004. The scanning electron microscopy (SEM) analyses showed that 

even with 24 hours the cells were capable to produce some extracellular matrix protein, because it was 

possible to observe some molecule on the cells and scaffolds surfaces. 

After implantation at the rabbit calvarial defects, all the scaffold groups were observed to be 

compatible with the soft and hard tissues, without showing any significant adverse reactions. No 

inflammatory cells were found in any of the specimens. Compared to the control group, wherein new bone 

formation most of the time it was limited only to the defect margin (Figure 6A), all of the scaffold groups 

showed a large amount of new bone formation, with the ingrowth of bony tissues into the pore channels 

(Figure 5 and 6). The same process was noted in our samples and defect control.  

Short time post-implantation, there was some edema, which it has been related as a normal 

physiological process of bone repair (Köse et al., 2004). In the implants or control defect, it was noted 

hemorrhage, as blood vessels, matrix destruction and probably death of bone cells around. During the 

healing, it is normal that the clot, wastes cells, and matrix are removed by macrophages, and the 

periosteum and endosteum near of the implant site response with an intense cell proliferation (Davies, 

2000). 

After one or two months the PHB samples shown more osteoids and new bone formation than the 

defect control, mainly the samples with cells (Figure 4 and 5). It was observed lots of agglomerated cells 

(Figure 5B-D). These are a common phenomenon described of cell condensations by large number of 

authors (Fell, 1925; Hall &amp;amp; Miyake 1992; Olsen et al, 2000; Shapiro 2008) that should happen before cell 

differentiation. It was unclear in this research those agglomerated cells are cells from the body and those 

cells migrated for the local lesion or if those cells were in the scaffold. We believe that both hypotheses 

could happen because even the PHB without cells it was observed some cells condensation, in a smaller 

proportion though. 

For long term post-implantation, we believed that the retard in the bone growth, in the group with 

PHB compared to the defect control should be due to the slow degradation of the polymer, which acts as a 

physical barrier avoiding the bone growth. On the other hand, for human being could be really useful if we 

consider the fact that human bone take at least 4 months to regenerate (Davies, 2005). And we should 

consider that apparently the same amount of bone was observed at the control defect. One of the major 

problems encountered by surgeons who deal with large bone defects is the difficulty of maintaining 



78 

 

viability within bone-grafted tissue in order to ensure graft survival and eventual restoration of the defect 

(Jan et al, 2006). In this study, the PHB had being shown suitable as a long term implant, and besides, the 

first step is designated a good material that it will be able to be use as bone in the future. 

It is known bone tissue has a great regenerative potential with the capacity to restore its structure 

and originals functions. There are situations when the bone defect is not to be able to regenerate by itself. 

In that case, could be necessary a bone graft to suitable treatment and good prognostic (Nair et al, 2007).  

A critical-sized defect is by definition the smallest full thickness osseous wound that will not heal 

spontaneously during the lifetime of an animal (Schmitz JP &amp;amp; Hollinger, 1986; Jan et al, 2006; Prado et 

al, 2006). According to Hollinger 1990, it was found experimentally that the CSD size for rabbits is 15 

mm or more. Although there are some authors using different sizes as a defect control. Kim et al. (2008b) 

investigate the in vivo performance of the engineered bioceramic scaffolds using a 10mm rabbit calvarial 

defect model. Hokugo et al. (2007) investigated the enhancement of biological function of platelet growth 

factors after integration of PRP into biomaterials, using a 5mm defect as a control in rabbit calvaria.  

 The rabbit calvarial defect model is analogous in many ways to clinical maxillofacial 

reconstruction. There is an osseous defect with a periosteal blood supply and there is a membranous 

pattern of bone repair and healing. One difference, however, is the presence of a pulsatile dural layer in 

the base of the rabbit calvarial model, which is not present in extracranial maxillofacial wounds (Ahmed et 

al, 2006). However, at the present study the animal model was suitable for our purpose. 

 A great number of biomaterials have been tested in the last decades for bone tissue engineering, 

but few have been demonstrated good results. Among the polymers, the PHB have been used as medical 

device and it has been shown good results in vivo and in vitro (Shishatskaya et al, 2004; Shishatskaya &amp;amp; 

Volova, 2004). A large amount of requirements are needed for a suitable material, and some of those are 

theirs architecture, and surface properties.  With the aim to improve these property of the materials for 

tissue engineering, scaffolds has been developing and the rapid prototyping appear as a great tool. 

Therefore, exploiting a scaffold with high porosity and interconnectivity in conjunction with high 

mechanical strength has been one of the important issues in the production of artificial bone grafts (Kim et 

al, 2008b). 

In this study, we used a specially designed three-dimensional PHB as scaffold to the osteoblast for 

filling out bone defects and improve bone augmentation. Bone is a complex and structured three-

dimensional tissue.  PHB scaffold developed with macrochanneled pores (200-500µm) shows ongoing 

increases in the cell proliferation. Although there are few in vivo studies reporting the effect of porosity 

using the PHB scaffolds, some limited number of works has been carried out using other types of 

materials. Roy et al. (2003) reported improved tissue ingrowth and new bone formation on the composite 

scaffolds (PLGA/tricalcium phosphate) by increasing the porosity, demonstrating that channel size, 

porosity, and pore size can be controlled and used to influence new bone formation and calvarial defect 

healing.  Hu et al 2009, suggested that the NF scaffolds resembling a native collagen fibrillar matrix, with 

appropriate pore sizes, and a high-porosity, effectively support osteogenesis of hMSCs showing 

mineralized bone formation. Tian et al, 2009 investigate in vivo biocompatibility and osteogenesis as well 

as degradability of the porous strontium-doped calcium polyphosphate (SCPP) scaffolds enhanced 

osteogenesis and degradability. According to Karageorgiou &amp;amp; Kaplan (2005), the porosity and pore size of 

biomaterial scaffolds play a critical role in bone formation. In vivo, higher porosity and pore size result in 

greater bone ingrowth. 



79 

 

To regenerate new bone tissues, the appropriate biological properties are required for cell 

scaffolds including good cell attachment/proliferation, differentiation function, and support of bone 

formation in three dimensions prior to vast degradation of the scaffold (Tanaka et al, 2008). Concerning 

the degradation, as seen in Figure 5B-D, the scaffolds implanted between calvaria bone and periosteum 

had maintained their three-dimensional structures at least 2 months. Importantly, new bone was found in 

the PHB scaffold. 

 According to our results all PHB scaffolds did not showed severe inflammatory response and 

allowed bone regeneration compare to defect control. PHB obtained by rapid prototyping, treatment by 

plasma and seeded cells onto scaffolds prior implant have been shown good techniques to obtain 

biocompatible, 3D scaffolds which it will improve bone regeneration, being promises to Tissue 

Engineering.  

 

 

CONCLUSION  

 

We conclude that the PHB scaffold with osteogenic cells could be useful as graft on flat bone 

tissue for the purpose of bone thickness augmentation improving regeneration. 

 

ACKNOWLEDGEMENTS  

 

The authors thank FAPESP (proc. 06/07147-3), Centro de Tecnologia da Informação Renato 

Archer (CTI), Laboratório Nacional de Luz Sincrotron (LNLS). 

 

REFERENCES  

 

ASTM F-981-93, (2004) Standard Practice for Assessment of Compatibility of Biomaterials for Surgical Implants 

with Respect to Effect of Materials on Muscle and Bone. Annual Book of American Society for Testing and Materials 

Standards. 

CHEN, L.J.; WANG, M. Production and evaluation of biodegradable composites based on PHB-PHV copolymer. 

Biomaterials, v.23, p.2631, 2002. 

 

CHIARINI, L.; FIGURELLI, S.; POLLASTRI, G.; TORCIA, E.; FERRARI, F.; ALBANESE, M.; NOCINI, P.F. 

Cranioplasty using acrylic material: A new technical procedure. J Craniomaxillofac Surg, v.32, p.5–9, 2004. 

 

CHOI, S.H.; CHEUNG, H.H. A multi-material virtual prototyping system. Comput Aided Des, v.37, p.123–136, 

2005. 

 

DAVIES, J.E. Bone Engineering. Hong Kong: Rainnbow graphic and Printing, 2000. 

  

DAVIES, C.M.; JONES, D.B.; STODDART, M.J.; KOLLER, K.; SMITH, E.; ARCHER, C.W.; RICHARDS, R.G. 

Mechanically loaded ex vivo bone culture system „Zetos?: systems and culture preparation. Eur Cell Mater, v.11, 

p.57-75, 2006. 

 

FELL, H.B. The histogenesis of cartilage and bone in the long bones of the embryonic fowl. J Morph Physiol, v.40, 

n.3, p.417-459, 1925. 

 



80 

 

GOGOLEWSKI, S.; JOVANOVIC, M.; PERREN, S.M.; DILLON, J.G.; HUGHES, M.K. Tissue response and in 

vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-

hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J. Biomed. Mater. Res. v.27, p.1135, 1993. 

 

GOGOLEWSKI, S. Bioresorbable Polymers in Repair, Replacement and Regeneration of Tissues and Organs. 

European Cells and Materials, v.7, S.1, p.32, 2004. 

  

HALL, B.K.; MIYAKE, T. The membranous skeleton: the role of cell condensations in vertebrate skeletogenesis. 

Anat Embryol, v.186, p.107-124, 1992. 

 

HOFMANN, M.P.; MOHAMMED, A.R.; PERRIE, Y.; GBURECK, U.; BARRALET, J.E. High-strength resorbable 

brushite bone cement with controlled drug-releasing capabilities. Acta Biomater. v.5. n.1, p.43-9, 2009. 

 

HOKUGO, A.; SAWADA, Y.; HOKUGO, R.; IWAMURA, H.; KOBUCHI, M.; KAMBARA, T.; MORITA, S.; 

TABATA, Y.. Controlled release of platelet growth factors enhances bone regeneration at rabbit calvaria. Oral Surg 

Oral Med Oral Pathol Oral Radiol Endod, v.104, n.1, p.44-8, 2007. 

 

HOLLINGER, J.O.; KLEINSCHMIDT, J.C. The critical size defect as an experimental model to test bone repair 

materials. J Craniofac Surg, v.1, p.60–68, 1990. 

 

HU, J.; FENG, K.; LIU, X.; MA, P.X. Chondrogenic and osteogenic differentiations of human bone marrow-derived 

mesenchymal stem cells on a nanofibrous scaffold with designed pore network. Biomaterials, v.30, n.28, p.5061-

5067, 2009. 

 

International Standard ISO 10993-6 (1994) Biological evaluation of medical devices - Part 6. 1-11. Jee, WS, Bartley, 

MJ, Cooper, R, Dockum. 

 

JAN, A.M.A.; SÁNDOR, J.K.B.; IERA, D.; MHAWI, A.; PEEL, S.; EVANS, A.W.; CLOKIE, C.M.L. Hyperbaric 

oxygen results in an increase in rabbit calvarial critical sized defects. Oral Surg Oral Med Oral Pathol Oral Radiol 

Endod, v.101, p.144-149, 2006. 

 

JIYA, T.; SMIT, T.; DEDDENS, J.; MULLENDER, M. Posterior lumbar interbody fusion using nonresorbable poly-

ether-ether-ketone versus resorbable poly-L-lactide-co-D,L-lactide fusion devices: a prospective, randomized study 

to assess fusion and clinical outcome. Spine (Phila Pa 1976), v.34, n.3, p.233-7, 2009.  

 

KARAGEORGIOU, V.; KAPLAN, D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials, v.26, 

n.27, p.5474-91, 2005. 

 

aKIM, S.S.; GWAK, S.J.; KIM, B.S. Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-

glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2. J Biomed Mater Res A, v.87, 

n.1, p.245-53, 2008. 

 

bKIM, H.W.; SHIN, S.Y.; KIM, H.E.; LEE, Y.M.; CHUNG, C.P.; LEE, H.H.; RHYU, I.C. Bone formation on the 

apatite-coated zirconia porous scaffolds within a rabbit calvarial defect. J Biomater Appl., v.22, n.6, p.485-504, 2008.  

 

KÖSE, G.T.; KORKUSUZ, F.; KORKUSUZ, P.; HASIRCI, V. In vivo tissue engineering of bone using poly(3-

hydroxybutyric acid-co-3-hydroxyvaleric acid) and collagen scaffolds. Tissue Eng., v.10, n.7-8, p.1234-50, 2004. 

 

LUCCHESI. C.; FERREIRA, B.M.; DUEK, E.A.; SANTOS JR, A.R.; JOAZEIRO, P.P. Increased response of Vero 

cells to PHBV matrices treated by plasma. J Mater Sci Mater Med, v.19, n.2, p.635-43, 2008.  

 

MAI, R.; HAGEDORN, M.G.; GELINSKY, M.; WERNER, C.; TURHANI, D.; SPÄTH, H.; GEDRANGE, T.; 

LAUER. G. Ectopic bone formation in nude rats using human osteoblasts seeded poly(3)hydroxybutyrate 

http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6WP1-4J4WCGF-B&amp;amp;_user=10&amp;amp;_coverDate=02%2F28%2F2006&amp;amp;_rdoc=10&amp;amp;_fmt=high&amp;amp;_orig=browse&amp;amp;_srch=doc-info(%23toc%236977%232006%23998989997%23615799%23FLA%23display%23Volume)&amp;amp;_cdi=6977&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;_ct=33&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=03c4c890119f2e7bf2edff27cfb67043
http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6WP1-4J4WCGF-B&amp;amp;_user=10&amp;amp;_coverDate=02%2F28%2F2006&amp;amp;_rdoc=10&amp;amp;_fmt=high&amp;amp;_orig=browse&amp;amp;_srch=doc-info(%23toc%236977%232006%23998989997%23615799%23FLA%23display%23Volume)&amp;amp;_cdi=6977&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;_ct=33&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=03c4c890119f2e7bf2edff27cfb67043


81 

 

embroidery and hydroxyapatite-collagen tapes constructs. Journal of Cranio-Maxillofacial Surgery, v.34, S2, p.101–

109, 2006. 

 

NAIR, M.; NAIR, U.; SEYEDAIN, A.; GASSNER, R.; PIESCO, N.; MOONEY, M.; GANTA, S.; AGARWAL, S. 

Correlation of tuned aperture computed tomography with conventional computed tomography for evaluation of 

osseous healing in calvarial defects. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and 

Endodontology. v.103, n.2, p.267-273, 2007. 

 

NEYT, J.G.; BUCKWALTER, J.A.; CARROLL, N.C. Use of animal models in musculoskeletal research. Iowa 

Orthop J, v.18, p.118-123, 1998.  

 

OLSEN, B.R.; REGINATO, A.M.; WANG, W. Bone development. Annu Rev Cell Dev Biol, v.16, p.191-220, 2000. 

 

ORÉFICE R.L.; PEREIRA, M.M.; MANSUR, H.S. Biomateriais: fundamentos e aplicações. Rio de Janeiro: Cultura 

Médica, 2006. 

 

PEARCE, A.I.; RICHARDS, R.G.; MILZ, S.; SCHNEIDER, E.; PEARCE. S.G. Animal models for implant 

biomaterial research in bone: a review. Eur Cell Mater, v.2, n.13, p.1-10, 2007. 

 

PRADO, A.F.; ANBINDER, A.L.; JAIME A.P.G.; LIMA A.P.; BALDUCCI I.; ROCHA R.F. Defeitos ósseos em 

tíbias de ratos: padronização do modelo experimental. Revista de Odontologia da Universidade Cidade de São 

Paulo, v.18, n.1, p.7-13, 2006. 

 

ROY, T.D.; SIMON, J.L.; RICCI, J.L.; REKOW, E.D.; THOMPSON, V.P.; PARSONS, J.R. Performance of 

degradable composite bone repair products made via three-dimensional fabrication techniques. J Biomed Mater Res 

A, v.66, n.2, p.283-91, 2003. 

 

SCHMIDT, C.; IGNATIUS, A.A.; CLAES, L.E. Proliferation and differentiation parameters of human osteoblasts 

on titanium and steel surfaces. J Biomed Mater Res, v.54, p.209-215, 2001. 

 

SHAPIRO, F. Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface 

osteoblasts. European Cells and Materials, v.15, p.53-76, 2008.  

 

SHISHATSKAYA, E.I.; VOLOVA, T.G. A comparative investigation of biodegradable polyhydroxyalkanoates 

films as matrices for in vitro cell culture. J Mater Sci Mater Med, v.15, p. 915-923, 2004. 

 

SHISHATSKAYA, E.I.; VOLOVA, T.G.; PUZYR, A.P.; MOGYLNAYA, O.A.; EFREMOV, S.N. Tissue response 

to the implantation of biodegradable polyhydroxyalkanoate suture. J Mater Sci Mater Med, v.15, p. 719-728, 2004. 

 

TANAKA, T.; HIROSE, M.; KOTOBUKI, N.; TADOKORO, M.; OHGUSHI, H.; FUKUCHI, H.; SATO, J.; SETO, 

K. Bone augmentation by bone marrow mesenchymal stem cells culture in three-dimension biodegradable polymer 

scaffolds. J Biom Res A, 2008. Epub ahead. 

 

TIAN, M.; CHEN, F.; SONG, W.; SONG, Y.; CHEN, Y.; WAN, C.; YU, X.; ZHANG. X. In vivo study of porous 

strontium-doped calcium polyphosphate scaffolds for bone substitute applications. J Mater Sci Mater Med, v.20, n.7, 

p.1505-1512, 2009. 

 

TUUSA, S.M.; PELTOLA, M.J.; TIRRI, T.; PUSKA, M.A.; RÖYTTÄ, M.; AHO, H.; SANDHOLM, J.; LASSILA, 

L.V.; VALLITTU, P.K. Reconstruction of critical size calvarial bone defects in rabbits with glass-fiber-reinforced 

composite with bioactive glass granule coating. J Biomed Mater Res B Appl Biomater, v.84, n.2, p.510-519, 2008. 

 

WANG, X.; MABREY, J.D.; AGRAWAL, C.M. An interspecies comparison of bone fracture properties. Biomed 

Mater Eng, v.8, p.1-9, 1998. 

 



82 

 

WANG, J.S.; DIAZ, J.; SABOKBAR, A.; ATHANASOU, N.; KJELLSON, F.; TANNER, K.E.; MCCARTHY, I.D.; 

LIDGREN, L. In vitro and in vivo biological responses to a novel radiopacifying agent for bone cement. J R Soc 

Interface, v.22, n.2, p.71-78, 2005. 

 

ZHENG, Z.; DENG, Y.; LIN, X.S.; ZHANG, L.X.; CHEN, G.Q. Induced production of rabbit articular cartilage-

derived chondrocyte collagen II on polyhydroxyalkanoate blends. J. Biomater. Sci.-Polym. Ed., v.14, p.615, 2003. 



83 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CAPÍTULO 5 



84 

 

 

CONCLUSÕES 

 
As blendas de PCL/PLGA paresentaram características desejáveis como dispositivos para 

aplicações em Engenharia de Tecido Ósseo, como adesão, proliferação celular e ausência de efeitos 

citotóxicos. 

Os arcabouços de PHB apresentaram boa viabilidade celular, não apresentam qualquer efeito 

citotóxico nos arcabouços independentes do tratamento por plasma. As modificações físico-químicas nos 

arcabouços por plasma de nitrogênio melhoraram a adesão celular. Os arcabouços permitiram a síntese de 

colágeno tipo I, sendo esta uma importante característica de células osteoblásticas. O processo de 

obtenção dos arcabouços de PHB por prototipagem rápida apresentou-se uma ótima técnica para o 

desenvolvimento de dispositivos tri-dimensionais aplicado a Engenhria de Tecidos.  

A interação célula/PHB/tecido mostrou-se promissora como suporte para o propósito de acelerar o 

reparo ósseo. Os arcabouços de PHB com células previamente cultivadas apresentaram maior formação 

óssea, sugerindo que a combinação do arcabouço e pré-cultivo celular facilitam a regeneração óssea, 

podendo ser utilizados para o preenchimento de defeitos ósseos. 

Os polímeros PCL, PLGA e PHB apresentaram boa interação com células osteoblásticas 

possibilitando a continuidade de seus estudos com aplicação à Engenharia de Tecidos Ósseos. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



85 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CAPÍTULO 6 

 



86 

 

REFERÊNCIAS BIBLIOGRÁFICAS 

 
ACKERMAN, L.V.; SPJUT, H.J.; ABELL, M.R. Bones and Joints. Baltimore: Williams and Wilkins. 1976. 
 
ALBERTS, B.; JOHNSON, A.; LEWIS, J.; et al. 5

th 
ed. Molecular Biology of the Cell. New York: Garland 

Science, 2005. 
 
AL-MUNAJJED, A.A.; PLUNKETT, N.A.; GLEESON, J.P.; WEBER, T.; JUNGREUTHMAYER, C.; 
LEVINGSTONE, T.; HAMMER. J.; O'BRIEN, F.J. Development of a biomimetic collagen-hydroxyapatite 
scaffold for bone tissue engineering using a SBF immersion technique. J Biomed Mater Res B Appl 
Biomater, v.90, n.2, p.584-591, 2009. 
 
ALBREKTSSON, T.; JOHANSSON, C. Osteoinduction, osteoconductionmand osseointegration. Eur Spine 
J, v.10, S.96–S101, 2001. 
 
ALBREKTSSON, T.; BRÅNEMARK, P.I.; HANSSON, H.A.; LINDSTRÖM, J. Osseointegrated titanium 
implants. Requirements for ensuring a long-lasting, direct bone anchorage in man. Acta Orthop Scand, 
v.52, p.155–170, 1981. 
 
ANSELME K. Osteoblast adhesion on biomaterials. Biomaterials, v.21, p.667–681, 2000. 
 
ATSAWASUWAN, P.; MOCHIDA, Y.; PARISUTHIMAN, D.; YAMAUCHI, M. Expression of lysyl oxidase 
isoforms in MC3T3-E1 osteoblastic cells. Biochemical and Biophysical Research Communications, v.327, 
p.1042–1046, 2005. 
 
BARBANI, N.; GIUSTI, P.; LAZZERI, L.; POLACCO, G.; PIZZIRANI, G. Bioartificial materials based on 
collagen: Collagen cross-linking with gaseous glutaraldehyde. J. Biomater. Sci. Polym. Ed., v.7, p.461–
469, 1995. 
 
BARBANTI, S.H.; SANTOS JR.; A.R., ZAVAGLIA, C.A.C.; DUEK, E.A.R. Porous and dense poly(L-lactic 
acid) and poly(D,L-lactic acid-co-glycolic acid) scaffolds: in vitro degradation in culture medium and 
osteoblasts culture. Journal of Materials Science: Materials in Medicine, v.15, p.1315-1321, 2004. 
 
BENIASH, E.; TRAUB, W.; VEIS, A.; WEINER, S. A transmission electron microscope study using vitrified 
ice sections of predentin: structural changes in the dentin collagenous matrix prior to mineralization. J. 
Struct. Biol v.132, n.3, p.212–225, 2000. 
 
BESSA, P.C.; CASAL, M.; REIS, R.L. Bone proteins in tissue engineering: the road from laboratory to 
clinic, part II. J Tissue Eng Regen Med, v.2, p.81-96, 2008. 
 
BORNSTEIN, P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 
1. J. Cell Biol., v.130, p.503-506, 1995. 
 
BOSKEY, A.L. Matrix Proteins and Mineralization: An Overview. Connective Tissue Res, v.35, n.1 -4, 
p.357-363, 1996. 
 
BRADLEY, W.G.; WILKES, G.L. Some mechanical property considerations of reconstituted collagen for 
drug release supports. Biomater. Med. Dev. Artif. Organs, v.5, p.159–175, 1977. 
 
BRADSHAW, A.D.; SAGE, E.H. SPARC, a matricellular protein that functions in cellular differentiation and 
tissue response to injury. J Clin Invest, v.107, p.1049-1054, 2001. 
 



87 

 

BRÅNEMARK, P.I.; HANSSON, B.O.; ADELL, R.; BREINE, U.; LINDSTRÖM, J.; HALLÉN, O.; ÖHMAN, 
A. Osseointegrated titanium implants in the treatment of the edentulous jaw. Scand J Plast Reconstr Surg, 
v.11, S.16, p:1–175, 1977. 
 
BREKKEN, R.A.; SAGE, E.H. SPARC, a matricellular protein: at the crossroads of cell-matrix 
communication. Matrix Biol, v.19, p.:816–827, 2001. 
 
RUDER, S.P.; CAPLAN, A.I. Bone regeneration through cellular engineering. LANZA, R.; LANGER, R.; 
VACANTI, J.  Principles in Tissue Engineering. San Diego: Academic Press, 2000, p.683-696. 
 
BUCKWALTER, J.A.; GLIMCHER, M.J.; COOPER, R.R.; RECKER, R. Bone biology. II: Formation, form, 
modeling, remodeling, and regulation of cell function. Instr Course Lect, v.45, p.387–99, 1996. 
 
BUCKWALTER, J.A.; GLIMCHER, M.J.; COOPER, R.R.; RECKER, R. Bone biology. I: Structure, blood 
supply, cells, matrix, and mineralization. Instr Course Lect., v.45, p.371–86, 1996. 
 
CHAN, C.-M. Polymer surface modification and characterisation. Hanser: Munich, 1993. 
 
CHU, P.K. et al  Plasma-surface modification of biomaterials.  Mater Sci Eng Ver, v.36, p.143-206, 2002. 
 
CHVAPIL, M.; SPEER, D.P.; HOLUBEC, H.; CHVAPIL, T.A.; KING, D.H. Collagen fibers as a temporary 
scaffold for 
replacement of ACL in goats. J. Biomed. Mater. Res., v.27, n.3, p.313–325, 1993. 
 
CLARKE, K.I.; GRAVES, S.E.; WONG, A.T.C.; TRIFFITT, J.T.; FRANCIS, M.J.O.; CZERNUSZKA, J.T. 
Investigation into the Formation and Mechanical-Properties of a Bioactive Material Based on Collagen and 
Calcium-Phosphate. J Mater Sci Mater Med, v.4, p.107-110, 1993. 
 
CRETU, A.; GATTIN, R.; BRACHAIS, L.; BARBIER-BAUDRY, D. Synthesis and degradation of poly (2-
hydroxyethyl methacrylate)-graft-poly (-caprolactone) copolymers. Polymer Degration and Stability. v.83, 
n.3, p.309-404, 2004.  
 
DALBY, M.J. et al.  Increasing fibroblast response to materials  using nanotopograhy: morphological and 
genetic measurements of cell response to 13 nm high polymer demixed island. Experimental Cell 
Research, v.276, p.1-9, 2002.  
 
DAMIEN, C.; PARSONS, R. Bone graft and bone graft substitutes: a review of current technology and 
applications. J. Appl. Biomat. v.2, p.187–208, 1991. 
 
DAS, S. et al Freeform fabrication of Nylon-6 tissue engineering scaffolds. Rapid Prototyping J, v.9, n.1, p. 
43–49, 2003. 
 
DATTA, H.K.; NG, N.F.; WALKER, J.A.; TUCK, S.P.; VARANASI, S.S. The cell biology of bone 
metabolism. J. Clin. Pathol. v.61, p.577-587, 2008. 
 
DENG, Z.-L.; SHARFF, K.A.;  TANG, N.; et al. Regulation of osteogenic differentiation during skeletal 
development. Frontiers in Bioscience, v.13, p.2001-2021, 2008. 
 
DESHPANDE, A.S.; BENIASH, E. Bio-inspired Synthesis of Mineralized Collagen Fibrils. Cryst Growth 
Des. v.8, n.8, p.3084-3090, 2008. 
 
DOUGALL, W.C.; CHAISSON, M. The RANK/RANKL/OPG triad in cancer-induced bone diseases. 
Cancer Metastasis Rev v.25, p.541-549, 2006. 
 



88 

 

DUCY, P.; SCHINKE, T.; KARSENTY, G. The osteoblast: a sophisticated fibroblast under central 
surveillance. Science, v.289, p.1501–4, 2000.  
 
DUEK, E.A.R.; ZAVAGLIA, C.A.C.; BELANGERO, W.D. In vitro study of poly(lactic acid) pin degradation. 
Polymer, v.40, p.6465-6473, 1999. 
 
EDE, D.A.;. AGERBAK, G.S. Cell adhesion and movement in relation to the developing limb pattern in 
normal and talpid3 mutant chick embryos. J. Embryol. exp. Morph. v.20,n.1, p.81-100, 1968. 
 
EL-TAMER, M.K.; REIS, R.L. Progenitor and stem cells for bone and cartilage regeneration. J Tissue Eng 
Regen Med., v.3, n.5, p.327-37, 2009. 
 
ERLEBACHER, A.; FILVAROFF, E.H.; GITELMAN, S.E.; DERYNCK, R. Toward a molecular 
understanding of skeletal development. Cell, v.80, p.371–378, 1995. 
 
FELL, H.B. The histogenesis of cartilage and bone in the long bones of the embryonic fowl. J Morph 
Physiol, v.40, n.3, p.417-459, 1925. 
 
FERREIRA, B.M.P.; ZAVAGLIA, C.A.C.; DUEK, E.A.R. Films of Poly(L-lactic acid)/Poly(hydroxybutyrate-
co-hydroxyvalerate) Blends: In Vitro Degradation. Materials Research, v.4, n.1, p.34-42, 2001. 
 
FERREIRA, B.M.P. et al. Films of PLLA/PHBV blends: Thermal, Morphological and Mechanical 
Characterization. J Applied Polym Sci, v.86, p. 2898-2906, 2002. 
 
FONSECA, M.J.; ALSINA, M.A.; REIG, F. Coating liposomes with collagen (Mr 50000) increases uptake 
into liver. Biochim. Biophys. Acta, v.1279, n.2, p.259–265, 1996. 
 
FUNK, S.E.; SAGE, E.H. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in 
bovine aortic endothelial cells. Proc Natl Acad Sci USA, v.88, p.2648-2652, 1991. 
 
GENGE, B.R.; WU, N.N.Y.; WUTHIER, R.E. Mineralization of Annexin-5-containing Lipid-Calcium-
Phosphate Complexes. The Journal Biological Chemistry, v.283, n.15, p.9737–9748, 2008. 
 
GIUSTI, P.; LAZZERI, L.; DE PETRIS, S.; PALLA, M.; CASCONE, M.G. Collagen-based new bioartificial 
polymeric materials. Biomaterials, v.15, n.15, p.1229-1233, 1994.  
 
GOISSIS, G.; MARGINADOR, S.V.S.; MARTINS, V.C.A. Biomimetic mineralization of charged collagen 
matrices: in vitro and in vivo study. Artif Organs, v.27, p.437-443, 2003. 
 
GÖPFERICH, A. Mechanisms of polymer degradation and erosion. Biomaterials, v.17, p.103-114, 1996. 
 
GOULD, S.E.; UPHOLT, W.B.; KOSHER, R.A. Syndecan 3: a member of the syndecan family of 
membrane-intercalated proteoglycans that is expressed in high amounts at the onset of chicken limb 
cartilage differentiation. Proc. Natl, Acad. Sci. USA, v.89, p.3271-3275, 1992. 
 
HALL, B.K.; MIYAKE, T. The membranous skeleton: the role of cell condensations in vertebrate 
skeletogenesis. Anat Embryol, v.186, p.107-124, 1992. 
 
HALL, B.K.; MIYAKE, T. Divide, accumulate, differentiate: cell condensation skeletal development 
revisited. Int. J. Dev. Biol., v.39, p.881-893, 1995. 
 
HALL, B.K.; MIYAKE, T. All for one and one for all: condensations and the initiation of skeletal 
development. Bio Essays ,v.22, p.138–147, 2000. 
 

http://www.ncbi.nlm.nih.gov/pubmed/19418440?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&amp;amp;ordinalpos=4


89 

 

HARADA, S.; RODAN, G.A. Control of osteoblast function and regulation of bone mass. Nature, v.423, 
p.349-355, 2003. 
 
HASIRCI, V. et al. Macroporous poly(3-hydroxybutyrate-co-3-hydroxyvalerate) matrices for bone tissue 
engineering. J Appl Polym Sci, v.87, 1949-1958, 2003. 
 
HEATH, D.; CRISTHIAN, P.; GRIFFIN, M. Involvement of tissue transglutinase in the stabilisation of 
biomaterials/tissue interfaces. Biomaterial, v.23, p.1519-1526, 2002. 
 
HENCH, L.L. Biomaterials: a forecast for the future.  Biomaterials, v.19, p.1419-1423, 1998. 
 
HODGE, A.J.; PETRUSKA, J.A. Electron Microscopy, Fifth International Congress for Electron 
Microscopy, Philadelphia, 1962, ed. BREESE JR, S.S. v.1. New York: Academic Press, 1962. vol. 1. 
 
HOFSTETTER, W.; WETTERWALD, A.; CECCHINI, M.G.; MUELLER, C.; FELIX, R. Detection of 
transcripts and binding sites for colony-stimulating factor-1 during bone development. Bone, v.17, p.145–
151, 1995. 
 
HOHENESTER, E.; MAURER, P.; TIMPL, R. Crystal structure of a pair of follistatin-like and EF-hand 
calcium-binding domains in BM-40. EMBO J, v.16, p.3778-3786, 1997. 
 
HOLLAND, P.W.; HARPER, S.J.; MCVEY, J.H.; HOGAN, B.L. In vivo expression of mRNA for the Ca

++
-

binding protein SPARC (osteonectin) revealed by in situ hybridization. J Cell Biol, v.105, p.473– 482, 
1987.  
 
HOKUGO, A.; SAWADA, Y.; HOKUGO, R.; IWAMURA, H.; KOBUCHI, M.; KAMBARA, T.; MORITA, S.; 
TABATA, Y. Controlled release of platelet growth factors enhances bone regeneration at rabbit calvaria. 
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. v.104, n.1, p.44-8, 2007 
 
HOLLINGER, J,O.; KLEINSCHMIDT, J.C. The critical size defect as an experimental model to test bone 
repair materials. J Craniofac Surg, v.1, p.60–68, 1990. 
 
HORTON, W.A. Morphology of connective tissue: Cartilage. In Connective tissue and its heritable 
disorders. New York: Wiley-Liss, 1993, p.73–84. 
 
HOWE, A.K.; APLIN, A.E.; JULIANO, R.L. Anchorage-dependent ERK signaling–mechanisms and 
consequences. Curr Opin Genet Dev, v.12, p.30–35, 2002. 
 
HUANG, L.F.; FUKAI, N.; SELBY, P.B.; OLSEN, B.R.; MUNDLOS, S. Mouse clavicular development: 
analysis of wild-type and cleidocranial dysplasia mutant mice. Dev. Dyn,. v.210, p.33–40, 1997. 
 
ISHAUG, S.L.; CRANE, G.M.; MILLER, M.J.; YASKO, A.W.; YASZEMSKI, M.J.; MIKOS, A.G. Bone 
formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed 
Mater Res, v.36, p.17–28, 1997. 
 
JAN, A.M.A.; SÁNDOR, J.K.B.; IERA, D.; MHAWI, A.; PEEL, S.; EVANS, A.W.; CLOKIE, C.M.L. 
Hyperbaric oxygen results in an increase in rabbit calvarial critical sized defects. Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod, v.101, p.144-149, 2006. 
 
JUNQUEIRA, L.C.; CARNEIRO, J. 11ªed. Histologia Básica. Rio de janeiro: Ed Guanabara Koogan, Rio 
de Janeiro, 2004. 
 
KANCZLER, J.M.; OREFFO, R.O.C. Osteogenesis and angiogenesis: the potential for engineering bone. 
European Cells and Materials, v.15, p.100-114, 2008. 

http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed?term=%22Hokugo%20A%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed?term=%22Sawada%20Y%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed?term=%22Hokugo%20R%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed?term=%22Iwamura%20H%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed?term=%22Kobuchi%20M%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed?term=%22Kambara%20T%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed?term=%22Morita%20S%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed?term=%22Tabata%20Y%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
javascript:AL_get(this,%20'jour',%20'Oral%20Surg%20Oral%20Med%20Oral%20Pathol%20Oral%20Radiol%20Endod.');
http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6WP1-4J4WCGF-B&amp;amp;_user=10&amp;amp;_coverDate=02%2F28%2F2006&amp;amp;_rdoc=10&amp;amp;_fmt=high&amp;amp;_orig=browse&amp;amp;_srch=doc-info(%23toc%236977%232006%23998989997%23615799%23FLA%23display%23Volume)&amp;amp;_cdi=6977&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;_ct=33&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=03c4c890119f2e7bf2edff27cfb67043


90 

 

 
KARSENTY, G. The genetic transformation of bone biology. Genes Dev. V.13, p.3037-3051, 1993. 
 
KAUFMANN, B.; MULLER, S.; HANISCH, F.G.; HARTMANN, U.; PAULSSON, M.; MAURER, P. et al. 
Structural variability of BM-40/SPARC/osteonectin glycosylation: implications for collagen affinity. 
Glycobiology v.14, p.609-619, 2004. 
 
KEEN, I. et al. Introducinh amine functionalities on a poly(3-hydroxybutirate-co-3-hydroxivalerate) surface: 
compring the use of ammonia plasma treatment and ethylenediamine aminolysis. Biomacromolecules, 
v.7, p.427, 2006. 
 
KIKUCHI, M.; MATSUMOTO, H.N.; YAMADA, T.; KOYAMA, Y.; TAKAKUDA, K.; TANAKA, J. 
Glutaraldehyde crosslinked hydroxyapatite/collagen self-organized nanocomposites. Biomaterials, v.25, 
p.63-69, 2004. 
 
KIM, B.S. et al.  Development of biocompatible synthetic extracellular matrcies for tissue engineering. 
Trends Biotechnol, v.16, p. 224-230, 2001. 
 
KIM, S.S.; PARK, M.S.; GWAK, S.J.; CHOI, C.Y.; KIM, B.S. Accelerated bonelike apatite growth on 
porous polymer/ceramic composite scaffolds in vitro. Tissue Eng, v.12, p.2997–3006, 2006. 
 
KNESER, U.; SCHAEFER, D.J.; POLYKANDRIOTIS, E.; HORCH, R.E. Tissue engineering of bone: the 
reconstructive surgeon's point of view. J. Cell. Mol. Med., v.10, n.1, p.7-19, 2006. 
 
KONG, L.; AO, Q.; WANG, A.; GONG, K.; WANG, X.; LU, G.; GONG, Y.; ZHAO, N.; ZHANG, X. 
Preparation and characterization of a multilayer biomimetic scaffold for bone tissue engineering. J 
Biomater Appl, v.22, p.223–239, 2007. 
  
KÖSE, G.T. et al. Poly(3-hydroxibutiric acid-co-3-hydroxyvaleric acid) based tissue engineering matrices. 
J Mater Sci Mater Med,  v.14, p. 121-6, 2003. 
 
LANDIS, J.L.; SILVER, F.H. The structure and function of normally mineralizing avian tendons. Comp 
Biochem Phys, v.133, p.1135–1157, 2002. 
 
LANE, T.F.; IRUELA-ARISPE, M.L.; SAGE, E.H. Regulation of gene expression by SPARC during 
angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1. J 
Biol Chem, v.267, p.16736-16745, 1992. 
 
LANE, T.F.; SAGE, E.H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB 
J, v.8, p.163–173, 1994. 
 
LANGER, R.; VACANTI, J.P. Tissue engineering, Sci, v.260, p.920-926, 1993. 
 
LANGOWSKI, B.A.; UHRICH, K.E. Microscale plasma-initiated patterning (muPIP). Langmuir, v.21, 
p.10509-14, 2005.  
 
LANZA R.P. et al.  Principles of tissue engineering. 2.ed. San Diego: Academic Press, p.101-110, 2000. 
 
LAVERY, K.; HAWLEY. S.; SWAIN, P.; ROONEY, R.; FALB, D.; ALAOUI-ISMAILI, M.H. New insights into 
BMP-7 mediated osteoblastic differentiation of primary human mesenchymal stem cells. Bone, v.45, p.27–
41, 2009. 
 
LEE, C.H.; SINGLA, A.; LEE, Y. Biomedical applications of collagen. Int J Pharmac, v.221, p.1–22, 2001. 
 



91 

 

LEFEBVRE, F.; PILET, P.; BONZON, N.; DACULSI, G.; RABAUD, M. New preparation and microstructure 
of the Endo-Patch elastin–collagen containing glycosaminoglycans. Biomaterials, v.17, p.1813–1818, 
1996. 
 
LEONG, K.F. et al. Solid freeform fabrication of tree-dimensional scaffolds for engineering replacement 
tissue and organs. Biomaterials, v.24, p.2363-2378, 2003. 
 
LI, R.H.; WOZNEY, J.M. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol, 
v.19, p.255-265, 2001. 
 
LUCCHESI C, FERREIRA BMP, DUEK EAR, SANTOS JÚNIOR AR, JOAZEIRO PP. Increased response 
of Vero cells to PHBV matrices treated by plasma. J Mater Sci Mater Med, v.19, n.2, p.635-643, 2008. 
 
LUCCHESI, C.; BARBANTI, S.H.; JOAZEIRO, P.P.; DUEK, E.A.R. Cell culture on PCL/PLGA blends. J 
Appl Polym Sci, v.115, n.5, p. 2609-2615, 2009.  
 
LUCIANO, R.; ZAVAGLIA, C.A.C.; DUEK, E. A. R, Synthesis And Caracterization of Porous Poly( Lactide 
Acid) Membranes: Study In Vitro And In Vivo. J Mater Science Mater Med, v.14, p. 1-8, 2002. 
 
LUDWIG, S.C.; KOWALSKI, J.M.; BODEN, S.D. Osteoinductive bone graft substitutes. Eur Spine J, v.9, 
S119-S125, 2000. 
 
MCPHERSON, J.M.; SAWAMURA, S.;  AMSTRONG, R. An examination of the biologic response to 
injectable, glutaraldehyde cross-linked collagen implants. J. Biomed. Mater. Res., V.20, p.93–107, 1986. 
 
MAEDA, M.; TANI, S.; SANO, A.; FUJIOKA, K. Microstructure and release characteristics of the 
minipellet, a collagen based drug delivery system for controlled release of protein drugs. J. Controlled. 
Rel., v.62, p.313–324, 1999. 
 
MARIE, P.A. Differenciation, fonction et controle de l’osteoblaste. Med Sci (Paris), v.17, 1252-1259, 2001. 
 
MARIE, PA. Transcription factors controlling osteoblastogenesis. Archives of Biochemistry and 
Biophysics, v.473, p.98–105, 2008. 
 
MARQUIS, M.E.; LORD, E.; BERGERON, E.; DREVELLE, O.; PARK, H.; CABANA, F.; SENTA, H.; 
FAUCHEUX, N. Bone cells-biomaterials interactions. Frontiers in Bioscience, v.14, p.1023-1067, 2009. 
 
MARRECO P.R.; da LUZ, M.P.; GENARI, S.C.; MORAES, A.M. Effects of different sterilizations methods 
of the morphology, mechanical properties, and cytotoxicity of chitosan membranes used has wound 
dressings. J Biomed Mater Res B Applied Biomaterial, v.15, p.868-77, 2004. 
 
MARTINEK, N.; ZOU, R.; BERG, M.; SODEK, J.; RINGUETTE, M. Evolutionary conservation and 
association of SPARC with the basal lamina in Drosophila. Dev Genes Evol, v.212, p.124-133, 2002. 
 
MARTINEK, N.; SHAHAB, J.; SODEK, J.; RINGUETTE, M. Is SPARC an Evolutionarily Conserved 
Collagen Chaperone? J Dent Res, v.86, n.4, p.296-305, 2007 
 
MAURER, P.; HOHENESTER, E. Structural and functional aspects of calcium binding in extracellular 
matrix proteins. Matrix Biol, v.15, p.569-580, 1997. 
 
MAURER, P.; SASAKI, T.; MANN, K.; GOHRING, W.; SCHWARZBAUER, J.E.; TIMPL, R. Structural and 
functional characterization of the extracellular calcium binding protein BM-40/secreted protein, acidic, rich 
in cysteine/osteonectin from the nematode Caenorhabditis elegans. Eur J Biochem, v.248, p.209-216, 
1997. 

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Lord%20E%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov/pubmed?term=%22Bergeron%20E%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov/pubmed?term=%22Drevelle%20O%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov/pubmed?term=%22Park%20H%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov/pubmed?term=%22Cabana%20F%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov/pubmed?term=%22Senta%20H%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract
http://www.ncbi.nlm.nih.gov/pubmed?term=%22Faucheux%20N%22%5BAuthor%5D&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract


92 

 

 
MESSIAS, A.D.; ARAGONES, A.; DUEK, E.A.R. PLGA-Hydroxyapatite Composite Scaffolds for 
Osteoblastic-Like Cells. Key Engineering Materials,  v.396-398, p.461-464, 2009. 
 
MIKOS, A.G.; SARAKINOS, G.; LEITE, S.M.; VACANTI, J.P. LANGER  Laminated three-dimensional 
biodegradable foams for use in tissue engineering. Biomaterials, v.14, p.323-330, 1993. 
 
MURATA, M.; MAKI, F.; SATO, D.; SHIBATA, T.; ARISUE, M. Bone augmentation by onlay implant using 
recombinant human BMP-2 and collagen on adult rat skull without periosteum. Clin. Oral Implants Res., 
v.11, n.4, p.289–295, 2000. 
 
NAKAGAWA, T.; TAGAWA, T. Ultrastructural study of direct bone formation induced by BMPs-collagen 
complex 
implanted into an ectopic site. Oral Dis., V.6, n.3, p.172–179, 2000. 
 
NEREM RM. Tissue engineering in the USA. Med Biol Eng Comput., v.30, n.4, CE8-12, 1992. Review. 
 
NETTI, P.A.; AMBROSIO, L.; NICOLAIS, L. Biofunctional materials for tissue reconsruction. In: 
International Conference on Advances of Biomaterials for Reconstructive Medicine. Capri, IL17, p.60, 
2002. 
 
NIMNI, M.E.; HARKNESS, R.D. Molecular structures and functions of collagen. In: Nimni, M.E. (Ed.), 
Collagen-Biochemistry, v.I. Boca Raton: CRC Press, p.1–79, 1988. 
 
O’BRIEN, F.J.; HARLEY, B.A.; YANNAS, I.V.; GIBSON, L. Influence of freezing rate on pore structure in 
freeze-dried collagen-GAG scaffolds. Biomaterials, v.25, p.1077-1086, 2004. 
 
OLSEN, B.R.; REGINATO, A.M.; WANG, W. Bone development. Annu Rev Cell Dev Biol, v.16, p.191-
220, 2000. 
 
PARK, T.G.; COHEN,S.; LANGER, R. Poly(L-lactic acid) Pluronic blends: characterization of phase 
separation behavior, degradation, and morphology and use as protein-releasing matrices. 
Macromolecules, v.25, p.116-122, 1992. 
 
PATINO, M.G.; NEIDERS, M.E.; ANDREANA, S.; COHEN, R.E. Collagen: an overview. Implant Dent, 
v.11, n.3, p.280-285, 2002. 
 
PATRICK, J.C.W. et al. editors. Frontiers in tissue engineering. New York: Pergamon, 1998. 
 
PEREIRA L.F.R.; CAMARGO M.C.L.; DIAS C.J.JR, BALDUINO A, LORA S, LANGONE F,BOROJEVIC R, 
BLANCO M.AM. Bone marrow stromal cells and resorbable collagen guidance tubes enhance sciatic 
nerve regeneration in mice. Exp Neurol, v.198, p. 457-68, 2006. 
 
PETER, S.J.; MILLER, M.J.; YASKO, A.W.; YASZEMSKI, M.J.; MIKOS AG. Polymer concepts in tissue 
engineering.  J. Biom. Mater. Res., v.43, p.422-427, 1998.  
 
PETITE, H.; RAULT, I.; HUC, A.; MENASCHE, P.H.; HERBAGE, D. Use of the acyl azide method for 
crosslinking collagen rich tissues such as pericardium. J. Biomed. Mater. Res., v.24, p.179–187, 1990. 
 
PETITE H, VIATEAU V, BENSAÏD W, MEUNIER A, DE POLLAK C, BOURGUIGNON M, OUDINA K, 
SEDEL L, GUILLEMIN G. Tissue-engineered bone regeneration. Nat Biotechnol., v.18, n.9, p.959-63, 
2000. 
 



93 

 

PRADO, A. F.; ANBINDER A.L.; JAIME A.P.G.; LIMA A.P.; BALDUCCI I.; ROCHA R.F. Defeitos ósseos 
em tíbias de ratos: padronização do modelo experimental. Revista de Odontologia da Universidade 
Cidade de São Paulo,  v.18, n.1, p.7-13, 2006. 
 
QIAN, Y.; YAO, G.; LIN, Z.; CHEN, J.; FAN, Y.; DAVEY, T.; XU, J.; ZHENG, M. Natural Bone Collagen 
Scaffold Combined with OP-1 for Bone Formation Induction In Vivo. J Biomed Mater Res Part B: Appl 
Biomater, v.90B, p.778–788, 2009. 
 
RALSTON, S. H.; AND, D.E.; CROMBRUGGHE, B. Genetic regulation of bone mass and susceptibility to 
osteoporosis. Genes Dev, v.20, p.2492-2506, 2006. 
 
REZENDE, C.A.; LUCCHESI, C.; PERIS-BARBO, M.L.; DUEK, E.A.R. Membranas de Poli(ácido lático-
co-ácido glicólico) como curativos para pele: degradação in vitro e in vivo. Polímeros, v.15, n.3, 323-238, 
2005. 
 
ROBEY, G.P.; FINDLAY, D.M.; YOUNG, M.F.; BERESFORD, J.N.; STUBBS, J.N.; FISHER, L.W.; 
TERMINE, J.D.  J.Bone Min. Res. V.1, p.288, 1986. 
 
ROBINSON, R.A. An electron-microscopic study of the crystalline inorganic component of bone and its 
relationship to the organic matrix. J Bone Joint Surg Am. v.34, p.389-476, 1952. 
 
ROMBERG, W. R.; WERNESS, P.G.; RIGGS, B. L.; MANN, K.G. Inhibition of hydroxyapatite crystal 
growth by bone specific and other calcium-binding proteins, Biochem., v.25, p.1176-1180, 1986. 
 
RUDERMAN, R.J.; WADE, C.W.R.; SHEPARD, W.D.; LEONARD, F. Prolonged resorption of collagen 
sponges: vaporphase treatment with formaldehyde. J. Biomed. Mater. Res., v.7, p.263–265, 1973. 
 
SCAPIN, S.M.; SILVA, D.R.;JOAZEIRO, P.P.; ALBERTO-RINCON, M.C.; LUCIANO, R.M., DUEK, E.A.R., 
Use of trietilcitrate plasticizer in the production of poly(L-lactic acid) implants with different degradation 
times. J Mater Sci Mater Med, v.14, p.635-40, 2003. 
 
SCHMITZ, J.P.; HOLLINGER, J.O. The critical size defect as an experimental model for 
craniomandibulofacial nonunions. Clin Orthop Res, v.205, p.299-308, 1986. 
 
SEAL, B.L.; OTERO, T.C.; PANITCH, A.  Polymeric biomaterials for tissue and organ regeneration.  
Mater. Sci. Eng. Res., v.34, p.147-230, 2001. 
 
SEFTON, M.V. Tissue engineering vital organs.  In: International Conference on Advances of Biomaterials 
for Reconstructive Medicine. Capri, v.19, p.62, 2002. 
 
SENA, L.A.; SERRICELLA, P.; BOROJEVIC, R.; ROSSI, A.M.; SOARES, G.A. Synthesis and 
characterization of hydroxyapatite on collagen gel. Key Eng Mater, v.254–256, p.493–496, 2004. 
 
SHAPIRO, F. Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts 
and surface osteoblasts. European Cells and Materials, v.15, p.53-76, 2008.  
 
SHI, X.; SITHARAMAN, B.; PHAM, Q.P.; LIANG, F.; WU, K.; BILLUPS. E.W.; WILSON, L.J.; MIKOS, A.G. 
Fabrication of porous ultrashort single-walled carbon nanotube nanocomposite scaffolds for bone tissue 
engineering. Biomaterials, v.28, p.4078–4090, 2007. 
 
SHISHATSKAYA, E.I.; KHLUSOV, I,A.; VOLOVA, T.G. A hybrid PHB-hydroxyapatite composite for 
biomedical application: production, in vitro and in vivo investigation. J Biomater Sci Polym Ed., v,17, n.5, 
p.481-98, 2006. 
 



94 

 

SILVA D.R. et al. In vivo interaction of cells on poly L-(lactic acid) membranes containing plasticizer. J 
Biomater Sci Polym Ed , v.17 , p.177, 2006. 
 
SODHI, R.N.S. Applications of surface analytical and modification techniques to biomaterials research.  J. 
Electr. Spectrosc. Phenom. v.81, p.269, 1996.  
 
STRELZOFF. Zur lehre den Knochentwicklung. Med. Cent, n.18, 1873. 
 
SUN, T.S.; GUAN, K.; SHI, S.S.; ZHU, B.; ZHENG, Y.J.; CUI, F.Z.; ZHANG, W.; LIAO, S,S. Effect of 
nano-hydroxyapatite/collagen composite and bone morphogenetic protein-2 on lumbar intertransverse 
fusion in rabbits. Chin J Traumatol, v.7, p.18–24, 2004. 
 
SUZUKI, S.; KAWAI, K.; ASHOORI, F.; MORIMOTO, N.; NISHIMURA, Y.; IKADA, Y. Long-term follow-up 
study of artificial dermis composed of outer silicone layer and inner collagen sponge. Br. J. Plast. Surg., 
v.53, n.8, p.659–666, 2000. 
 
SWEETWYNE, M.T.; BREKKEN, R.A.; WORKMAN, G.; BRADSHAW, A.D.; CARBON, J.; SIADAK, A.W.; 
MURRI, C.; SAGE, E.H. Functional Analysis of the Matricellular Protein SPARC with Novel Monoclonal 
Antibodies. Journal of Histochemistry &amp;amp; Cytochemistry, v.52, n.6, p.723–733, 2004. 
 
TERMINE, J.D.; KLEINMAN, H.K.; WHITSON, S.W.; CONN, K.M.; MCGARVEY, M.L.; MARTIN, G.R. 
Osteonectin, a bone-specific protein linking mineral to collagen. Cell v.26, p.99-105, 1981. 
 
TORMALA, P.; DAVIDSON, C.L.; KLOPPER, P.J.; LINCLAU. L.A. Tissue response to a braided poly-L-
lactide implant in an experimental reconstruction of anterior cruciate ligament. J. Mat. Sci. Mater. Med. 
V.4, p.547, 1993. 
 
TREMBLE, P.M.; LANE, T.F.; SAGE, E.H.; WERB, Z. SPARC, a secreted protein associated with 
morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a 
novel extracellular matrix-dependent pathway. J Cell Biol, v.121, p.1433-1444, 1993. 
 
TU, R.; LU, C.L.; THYAGARAJAN, K.; WANG, E.; NGUYENM, H.; SHEN, S.; HATA, C.; QUIJANO, R.C. 
Kinetic study of collagen fixation with polyepoxy fixatives. J. Biomed. Mater. Res., v.27, p.3–9, 1993. 
 
VAANANEN, K.: Mechanism of osteoclast mediated bone resorption – rationale for the design of new 
therapeutics. Adv Drug Deliv Rev v.57, p.959-971, 2005. 
 
van DER STRICHT, O. recherché sur le cartilage articulaire des oiseaux. Arch de Biol., t.10, p.1, 1890. 
 
van KOOTEN et al. Plasma-treated polysterene surfaces: model surfaces for studying cell-biomaterial 
interactions. Biomaterials, v.25, p. 1735-1747, 2004. 
 
VERDELIS, K.; LING, Y.; SREENATH, T.; HARUYAMA, N.; MACDOUGALL, M.; VAN DER MEULEN, 
M.C.H.;  LUKASHOVA, L.; SPEVAK, L.; KULKARNI, A.B.; BOSKEY, A.L. DSPP Effects on in vivo Bone 
Mineralization. Bone, v.43, n.6, p.983-990, 2008. 
 
VERT, M.; LI, M. S.; SPENLEHAUER, G. &amp;amp; GUERIN, P. Bioresorbability and biocompatibility of aliphatic 
polyesters. J Mater Sci Mater Med, v.3, p.432, 1992.  
 
VOLOVA, T. et al. Results of biomedical investigations of PHB and PHB/PHV fibers. Biochemical Eng J, 
v.16, p.125, 2003. 
 
WAHL, D.A.; CZERNUSZKA, J.T. Collagen-hydroxyapatite composites for hard tissue repair. Eur Cell 
Mater., v.28, n.11, p.43-56, 2006. 



95 

 

 
WAN, Y. et al. Adhesion and proliferation of OCT-1 osteoblast-like cells on micro- and nono-scale 
topography structured poly (L-lactide). Biomaterials, v.26, p.4453-4456, 2005. 
 
WANG, H.; FERTALA, A.; RATNER, B.D.; SAGE, E.H.; JIANG, S. Identifying the SPARC binding sites on 
collagen I and procollagen I by atomic force microscopy. Anal Chem, v.77, p.6765-6771, 2005. 
 
WATSON, M.L; ROBINSON, R.A. Collagen-crystal relaships on bone. II. Electron microscopy study of 
basic calcium phosphate crystals. Am J Anat, v93, p.25, 1953. 
 
WEINER, S.; TRAUB, W. Crystal size and organization in bone. Connect Tissue Res, v.21, p.259–65, 
1989.  
 
WEINER, S.; WAGNER, H.D.  Bone fractures. Bone, v.26, n.6, p.875-876, 2000. 
 
WILLIAMS, D.F. (ed), Definitions in Biomaterials - Progress in Biomedical Engineering, Elsevier, v.4, 
Cap.1, 1987. 
 
WILLIAMS, D.F. Revisiting the definitions of biocompatibility. Medical devices techonology, v.14, n.8, 
p.10-13, 2003. 
 
WILLIAMS, J. M. et al Bone tissue engineering using Polycaprolactone scaffolds fabricated via selective 
laser sintering. Biomaterials, v.26, p. 4817-4827, 2005. 
 
WILSON-HENCH, J. Osteoinduction. WILLIAMNS, D.F. (ed) Progress in biomedical engineering, v.4. 
Definitions in biomaterials. Elsevier, Amsterdam, p.29, 1987. 
 
WOOLEY, D.E. Mammalian collagenases. PIEZ, K.A., REDDI, A.H. (Eds.), Extracellular Matrix 
Biochemistry. New York: Elsevier, p.119–158, 1984. 
 
World Health Organization: The burden of musculoskeletal conditions at the start of the new millennium. 
WHO Technical Report Series, 919, 2003. World Health Organization, Geneva (Switzerland), 2003. 228 p. 
 
YAMAGUCHI, M. et al. M. Surface modification of poly(L-lactic acid) affects initial cell attachment, cell 
morphology, and cell growth. J Artif Organs, v.7, p.187-193, 2004. 
 
YEONG, W.-Y. et al. Rapid prototyping in tissue engineering: challenges and potential. Trends Biotechnol, 
v.22, n.12, 2004. 
 
ZENG, G.-Z.; TAN, N.-H.; HAO, X.-J.; MU, Q.-Z.; LIA, R.-T. Natural inhibitors targeting osteoclast-
mediated bone resorption. Bioorg Med Chem Lett, v.16, p.6178–6180, 2006. 
 
ZOPPI, R.A.; BARROS, P.P.; CORAÇA, D.C.; DUEK, E.A.R. Preparation and characterization of poly(L-
lactic acid) and poly(ethylene oxide) blends. Materials Research. v.4, n.2, p.117-125, 2001. 

 

 

 

javascript:AL_get(this,%20'jour',%20'Bone.');


96 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

APÊNDICE



97 

 



98 

 

 


</field>
	</doc>
</add>